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I. Executive summary 
Diabetes is a chronic physical health condition characterised by abnormally 
high blood glucose levels. Careful self-management is an important part of treatment, 
with all individuals with type 1 diabetes (T1D) and some individuals with poorly 
controlled type 2 diabetes (T2D) requiring insulin therapy. Individuals not only 
experience the daily challenge of balancing their blood glucose levels to reduce the 
risk of developing physical complications, but also can face significant psychosocial 
challenges. These difficulties can be barriers to achieving treatment goals, increasing 
the risk of complications and subsequently the economic burden of diabetes. 
Systematic review 
It is vital people with diabetes have access to effective interventions that target 
well-being and self-management. However, the evidence base for existing 
psychosocial interventions is mixed. Given that individuals can have internal 
experiences that accurately reflect the possibility of realistic consequences, 
challenging these can have limited effectiveness. Acceptance and Commitment 
Therapy (ACT) may be a solution as it moves away from attempts to reduce distress 
directly or to alter beliefs, and instead attempts to reduce the influence of difficult 
internal experiences on individuals’ behaviour. Interest in ACT has risen as a 
promising approach for supporting people with diabetes. 
The systematic review aimed to investigate the characteristics of ACT 
interventions for people with diabetes, and to what extent ACT improves the 
psychological, behavioural and physical outcomes of people with T1D and T2D. 
Database searches (PubMed, Web of Science and PsycINFO) were conducted on 15th 
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September 2019 using search terms related to diabetes and ACT, alongside searches 
of the grey literature and reference lists. Two reviewers independently completed title, 
abstract and full-text screens. Studies were included if they: used a quantitative 
experimental or quasi-experimental design; recruited participants with T1D and/or 
T2D; investigated ACT-based intervention(s) which included components of 
acceptance and committed action; and measured diabetes-related outcomes using 
standardised tools. A quality assessment was completed using the Effective Public 
Health Practice Project Quality Assessment Tool, followed by a narrative synthesis. 
Overall, 87 unique records were identified, of which 70 studies were excluded 
due to not fulfilling criteria and 17 studies were eligible for review. The studies 
employed a range of research designs and included 14 peer-reviewed journal articles, 
two unpublished theses and one report. A control/comparison condition was used in 
13 studies. All studies used pre- and post-intervention measurements, and six studies 
included a follow-up. Twenty different general and diabetes-specific psychological 
outcomes had been investigated. Behavioural outcomes mainly focused on diabetes 
self-management, whilst physical outcomes were primarily based on glycated 
haemoglobin levels (HbA1c), a measure of glycaemic control over the last three 
months. Seven studies investigated ACT process outcomes. 
A total sample size of 827 was included, belonging to a range of ethnicities 
although at least half were likely Iranian. Fourteen studies targeted adults and three 
studies targeted children. Thirteen studies recruited individuals with T2D, one study 
recruited individuals with T1D, and three studies recruited people with either 
diagnosis. The studies generally aimed to develop a feasible ACT-based intervention, 
to investigate the effectiveness of ACT, and/or to investigate mechanisms of change. 
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Although a range of formats had been utilised, group interventions (n = 13) were most 
commonly investigated. The number of sessions varied from 1 to 15, and the total 
intervention length varied between 1 and 90 days. All ACT components were 
captured by the studies. Information on delivery providers (n = 8) and treatment 
fidelity (n = 2) was provided by few studies. Most studies obtained an overall quality 
rating of “weak” (n = 13), followed by “moderate” (n = 3) and “strong” (n = 1). 
The T2D studies revealed post-intervention improvements of small to large 
effect sizes for outcomes such as diabetes self-care, physical activity, diabetes-related 
distress, self-efficacy, perceived stress, general mental health, worry and quality of 
life. Inconsistent results were identified for depression, anxiety, ACT-related 
processes and HbA1c. The only study into T1D identified a small to medium 
improvement in diabetes acceptance but no significant changes in HbA1c and 
psychological outcomes. The studies investigating combined populations identified 
post-intervention improvements in diabetes self-management and a range of 
psychological outcomes including depression, resilience and well-being. 
Strengths of the review included using a second reviewer and applying 
corrections to intervention effect sizes for small sample bias. However, the 
heterogeneity of the studies, combined with the limited literature, made drawing firm 
conclusions difficult. The review raised concerns regarding the lack of clarity around 
treatment content and fidelity, therapist training, and power calculations. Further, 
weaknesses were identified in the robustness of employed research designs, the use of 
generic outcome measures and reduced control over potential confounding factors, 
which may have contributed towards inconsistent results. 
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Although not substantive, the results were promising and demonstrated the 
acceptability and feasibility of delivering ACT to the diabetes population. The 
findings suggest that ACT may have the potential to address a future direction in 
diabetes care delivery, but high-quality research is needed first. Recommendations for 
future research include further investigating the impact of ACT in T1D populations, 
examining clinically significant impact, using robust study designs, reaching a 
consensus on standardised diabetes-related measures, and increasing transparency. 
Empirical study 
Due to the lack of psychology funding, many patients with diabetes do not 
have access to appropriate and effective psychological therapies, such as ACT in 
diabetes services. The use of brief online, modular interventions may be a solution to 
address this issue as they may target specific coping strategies and diabetes-related 
outcomes. Karekla and colleagues’ (2018) theoretical mapping of ACT components 
onto the Common Sense Model of illness self-regulation provided a framework for 
the pilot study. The study aimed to investigate the impact of two online four-week, 
self-help interventions based on ACT components (a values-plus-goals intervention 
[VGI] and a mindfulness-based intervention [MBI]) on the well-being, diabetes self-
management and glycaemic control of insulin-treated adults with suboptimal 
glycaemic control and to determine whether improvements in these outcomes were 
associated with changes in diabetes acceptance and valued living. 
A randomised controlled mixed design was used. Fifty-six insulin-treated 
individuals, recruited through diabetes clinics at an NHS trust and diabetes 
organisations, were randomly assigned to the VGI or the MBI group. Following 
attrition, the final sample size was 29 (MBI: n = 12; VGI: n = 17). The sample were 
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predominantly middle-aged English-speaking adults with T1D (76%), male (55%) 
and from a White ethnic background (97%), with an average diabetes duration of 21.9 
years. In the VGI, participants were asked to complete a values-clarification card-sort 
task and to connect with their top value. Participants then set a diabetes-related 
SMART goal to achieve in one month. In the MBI, participants were introduced to 
mindfulness and asked to complete a 10-minute practice adapted for diabetes. 
Participants were asked to complete the practice three to four times a week for one 
month. 
Sociodemographic characteristics were collected at baseline. The following 
standardised questionnaires were completed pre-intervention, post-intervention and at 
follow-up: Well-being Questionnaire; Diabetes Self-Management Questionnaire; 
Diabetes Acceptance Scale; and Valued Living Questionnaire. HbA1c level was 
obtained at baseline and follow-up. Participants also completed a post-intervention 
feedback questionnaire. Data was analysed using Huyhn-Feldt corrected repeated 
measures analysis of variance and multiple linear regression. Reliable Changes 
Indices and clinically significant changes were also examined. 
Attrition rates did not significantly differ between the treatment groups (p = 
.289). However, individuals with more hypoglycaemic episodes (p = .033), higher 
diabetes acceptance (p = .028) and higher well-being (p = .019) were more likely to 
complete the study. Participants in the MBI and VGI groups took on average 46.4 and 
53.5 days respectively to complete the intervention. The MBI group completed 12 
mindfulness practices on average during the programme. Twelve participants in the 
VGI group moved towards their value-based goal and five could not due to external 
factors. Both interventions were experienced as somewhat helpful, relevant and easy 
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to use. Ten participants in the MBI group and nine participants in the VGI group 
would recommend the programmes. 
In the MBI condition, participants experienced non-significant improvements 
in their well-being and diabetes acceptance over time. Two participants experienced 
clinically significant improvements in their well-being. Participants’ post-intervention 
well-being was significantly associated with changes in diabetes acceptance, 
controlling for their baseline well-being. However, this association was not significant 
at follow-up. 
In the VGI condition, participants showed a non-significant positive trend in 
their diabetes self-management (p = .061, ηp2 = .270) with post-hoc t-tests revealing a 
significant increase between pre-intervention and post-intervention (p = .009, d = 
.504), which was maintained at follow-up (p = .020, d = .46). Subscale analyses 
revealed that only the dietary control component of self-management significantly 
improved over time (p = .01, ηp2 = .411), with post-hoc t-tests identifying significant 
improvements from pre-intervention to post-intervention (p = .005, d = .478) and 
follow-up (p = .020, d = .46). Clinically significant improvements were noted in three 
participants for dietary control and in two participants for level of physical activity. A 
non-significant improvement in valued living was found over the course of the study. 
No significant associations were found between changes in valued living and diabetes 
self-management at post-intervention and follow-up, controlling for baseline diabetes 
self-management. Follow-up HbA1c values were obtained for five participants, 
precluding statistical analysis. Of these, four participants experienced clinically 
meaningful reductions at follow-up. 
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Overall, the hypotheses that the MBI would significantly improve well-being 
and diabetes acceptance were not supported, although they were significantly 
associated. The hypothesis that the VGI would increase diabetes self-management 
was partially supported, although this was found to be specific to dietary control. 
However, valued living did not improve and was not associated with changes in 
diabetes self-management as hypothesised. Promising improvements were identified 
for glycaemic control for a small number of participants.  
Several study limitations were noted including shortfalls in the interventions, 
methodological drawbacks such as the use of self-report and lack of personalised 
feedback, and confounding factors such as diabetes duration, motivation level and 
external factors. An overarching issue was the small samples obtained, which led to 
an underpowered study and precluded cross-comparisons of the interventions.  
The results in relation to diabetes self-management, dietary control and 
glycaemic control, combined with participant feedback on the feasibility, accessibility 
and relevance of the interventions, were indicative of the interventions’ potential in 
expanding access to psychological input. This in turn may reduce complications and 
the economic burden of diabetes. However, further research is necessary to gain more 
insight into the clinical benefits of these interventions for individuals with diabetes 
using more rigorous studies with larger sample sizes and longer follow-ups.  
Integration, impact and dissemination 
The pilot study aimed to extend previous ACT for diabetes literature in a 
pragmatic way, with a view to facilitating real-life application and informing future 
trials. The systematic review confirmed the novel aspects of the empirical study, such 
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as contributing to the ACT for T1D literature, and being the first study to have 
examined ACT components in the diabetes field. Further, it incorporated an active 
control group and was transparent about intervention details. Delays in obtaining 
ethics approval, combined with limited resources, resulted in barriers such as reduced 
assistance with recruitment. Moreover, using a flexible approach to recruitment 
difficulties introduced confounding factors. Piloting the study and increasing 
collaboration with the diabetes team would have been beneficial to gain a better 
insight into these challenges. Pragmatic trials may also increase understanding of the 
feasibility of online ACT-based interventions in this population. Service user 
feedback helped to assess the relevance of the project and adapt research materials. 
The interventions showed promise as a feasible and acceptable way of 
improving self-management and potentially HbA1c. The interventions could have 
broader benefits for clinicians, the National Health Service and diabetes organisations. 
They could reduce the economic burden of diabetes and save time, money and 
resources. The study has raised awareness of the importance of considering well-
being, mindfulness and value-based living – aspects which are often missed in routine 
care. This may encourage services to address local needs, which may translate into 
policy-driving work in the future. However, as the study was a pilot, more robust 
randomised controlled trials are needed to establish the effectiveness of ACT 
component-based interventions for the diabetes population. The systematic review 
provides researchers with a foundation to build on with recommendations, whilst the 
pilot study has highlighted implementation challenges to inform future research. 
Several dissemination routes are proposed to maximise the impact of the 
project. These include: providing participants, local Diabetes UK groups and key 
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diabetes organisations with a plain English summary of the findings; providing a 
formal summary to the collaborating diabetes team with a service user, highlighting 
the recommendations that are most pertinent to clinical practice; submitting the 
systematic review and empirical study to a peer-reviewed diabetes journal; and 
presenting the empirical study at the UK & Ireland Association for Contextual 
Behavioural Science 2020 conference. 
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I. The impact of Acceptance and Commitment Therapy (ACT) on the 
psychological, behavioural and physical outcomes of people with diabetes:  
a systematic review 
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Abstract 
Acceptance and Commitment Therapy (ACT) has been researched as a promising 
approach to address the psychosocial impact of diabetes. However, a systematic review 
of the evidence base for ACT for diabetes has not been conducted to date. The present 
review aimed to explore the characteristics of ACT interventions for diabetes and to 
examine whether ACT improves diabetes-related outcomes in people with type 1 
diabetes (T1D) and type 2 diabetes (T2D). A systematic literature search was 
undertaken of three databases (PubMed, Web of Science and PsycINFO) and the grey 
literature in September 2019 to identify any quantitative studies that have investigated 
the impact of ACT on diabetes-related psychological, behavioural and/or physical 
outcomes. Following title, abstract and full-text paper screens, 17 studies were included 
in the review for quality appraisal and narrative synthesis. The interventions employed 
in these studies varied in their delivery format, duration and components. Thirteen 
studies found that ACT led to improvements of small to large effect sizes for several 
outcomes, such as diabetes-related distress and diabetes self-management, in the T2D 
population. The heterogeneity of psychological outcomes hindered cross-study 
comparisons. Inconsistent results were identified for depression, anxiety, ACT-related 
processes and HbA1c. One study investigated ACT in adolescents with T1D, precluding 
generalisation. Three studies examined combined populations, finding post-ACT 
improvements in a range of outcomes, although diabetes type may have been a 
confounding factor. The review raised concerns regarding reporting bias and 
methodological issues, which may have contributed towards inconsistent results. 
Overall, the findings suggest that ACT may have the potential to address a future 
direction in diabetes care delivery, but high-quality research is needed to draw firmer 
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conclusions about its effectiveness. Recommendations for future research include using 
robust study designs, reaching a consensus on standardised diabetes-related measures, 
and increasing transparency about ACT interventions. 
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Introduction 
Diabetes mellitus refers to a chronic physical health condition characterised by 
abnormally high blood glucose levels. Common symptoms include increased fatigue, 
excessive thirst, frequent urination and unintentional weight loss (Diabetes UK, 
2019). There are various types of diabetes, such as type 1 diabetes (T1D), type 2 
diabetes (T2D), cystic fibrosis-related diabetes, latent autoimmune diabetes in adults 
(LADA), monogenetic diabetes and diabetes caused by rare genetic syndromes (Royal 
College of Nursing [RCN], 2019). The prevalence of diabetes is rapidly growing with 
3.8 million people in the United Kingdom (UK) with a diagnosis, out of whom 
approximately 8% have T1D and 90% have T2D – the two main types of diabetes 
(Diabetes UK, 2019). The National Health Service (NHS) spends approximately 10% 
of its yearly budget on diabetes care, primarily due to the cost of treating diabetes-
related complications, indicating that diabetes has a significant economic burden 
(Diabetes UK, 2017). 
T1D and T2D have different pathophysiological mechanisms distinguished by 
their relationship to insulin, a pancreatic hormone responsible for allowing cells to use 
glucose for energy and for lowering blood glucose levels (Diabetes UK, 2019). T1D 
is considered to be an autoimmune disease where insulin-secreting beta-cells in the 
pancreas (islets of Langerhans) have been destroyed by the immune system, resulting 
in no or minimal insulin being produced and high blood glucose levels. It is thought to 
be caused by both genetic and environmental factors, although the exact causes are 
unknown (RCN, 2019). The onset of T1D is typically before the age of 40. It used to 
be referred to as “juvenile diabetes” as it often develops during childhood or 
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adolescence, but it is now known that more than half of those newly diagnosed with 
T1D are over 18 years of age (Juvenile Diabetes Research Foundation [JDRF], n.d.). 
T2D is generally more prevalent in adults (Diabetes UK, 2019).  In T2D, 
pancreatic beta-cells can produce insulin, but cells have developed insulin resistance. 
Although the pancreas attempts to overcome the resistance through increased insulin 
production, the cells become impaired and unable to do so over time, leading to 
insufficient insulin secretion and inadequate control over blood glucose levels (RCN, 
2019). Genes, environmental factors and physical health factors such as obesity and 
lack of exercise have been identified as risk factors towards the development of T2D, 
although the exact causal mechanisms remain unknown (RCN, 2019).  
Physical complications of diabetes 
Individuals with poorly controlled blood glucose levels have an increased risk 
of developing acute physical complications, such as hypoglycaemia (dangerously low 
blood glucose) and diabetic ketoacidosis (build-up of ketones in the body). Extreme 
hyperglycaemia (high blood glucose levels) can lead to hyperglycaemic hyperosmolar 
nonketotic syndrome, a life-threatening condition (Mayo Clinic, 2018). 
Hypoglycaemia, if not treated, can be dangerous, leading to loss of consciousness and, 
rarely, seizures, coma and death. Over time, with frequent episodes of hypoglycaemia, 
some individuals can develop hypoglycaemia unawareness where blood glucose 
levels drop to dangerous levels, but they do not get any of their usual warning 
symptoms. 
Controlling blood glucose levels well is important if individuals are to avoid 
the risk of developing physical complications. Diabetes increases the risk of 
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developing macrovascular complications, such as heart disease, peripheral vascular 
disease and stroke, and microvascular complications such as diabetic nephropathy, 
neuropathy and retinopathy (Fowler, 2008). These complications can be disabling and 
life-threatening, contributing to most of the morbidity and mortality in both T1D and 
T2D (George et al., 2014). 
Diabetes management 
There are similarities between the management of T1D and T2D alongside 
some key differences (Diabetes UK, 2019). Self-management is an important aspect 
of both T1D and T2D management: individuals are advised to take responsibility in 
administering their medication, and in making and maintaining substantial lifestyle 
changes (George et al., 2014). Individuals with T1D control their blood glucose levels 
by injecting insulin, using an insulin inhaler or through continuous subcutaneous 
insulin infusion. There are three categories of insulin therapy with differing time-
action profiles: short-acting, intermediate-acting and long-acting. The time-action 
profiles can vary significantly between individuals, which adds to the complexity of 
diabetes management (National Institute for Health and Care Excellence [NICE], 
2015). Alongside insulin therapy, individuals must learn to calculate the amount of 
carbohydrates they are consuming and regularly monitor their blood glucose levels to 
ensure that they are in their target range (Bonora & DeFronzo, 2018; George et al., 
2014). Individuals with T2D typically take oral antidiabetic medications to manage 
their blood glucose levels, although insulin therapy is also used in more severe cases 
(DeWitt & Hirsch, 2003; George et al., 2014). They must make and maintain lifestyle 
changes such as healthy eating and regular exercise, as well as engage in regular 
blood glucose monitoring (Bonora & DeFronzo, 2018). 
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Whilst the aforementioned physical complications are possible outcomes in 
both T1D and T2D, individuals on insulin treatment face a continuous challenge of 
balancing their blood glucose levels throughout their day to avoid hypoglycaemia and 
hyperglycaemia. They must monitor their blood glucose levels more frequently and 
adjust their insulin doses accordingly; sometimes a continuous glucose monitor 
(CGM) is used to facilitate this process (Bonora & DeFronzo, 2018). Further, blood 
glucose levels can change unpredictably even with careful management due to 
additional factors such as illness and physical activity (Mayo Clinic, 2018). Data from 
the National Diabetes Audit in 2016-17 indicated that only 40.8% of adults with T2D 
and 18.9% of adults with T1D achieved target glycaemic control, blood pressure and 
cholesterol results (Health and Social Care Information Centre, 2017). The significant 
health challenge posed by diabetes is also compounded by its psychosocial impact on 
individuals. 
Psychosocial impact of diabetes 
Individuals with diabetes can face significant psychosocial challenges as a 
result of the demands of diabetes care and the difficulties of integrating it into daily 
life (Nash, 2014). Nicolucci and colleagues examined psychosocial outcomes of 
people with diabetes across 17 countries in 2013, finding that 20% of people felt that 
their diabetes care was impacting on their relationships with family and friends, and 
40% felt that it interfered with their day-to-day functioning. According to recent 
statistics in the UK, approximately 40% of people with diabetes experience 
psychological difficulties and up to 65% can experience low mood related to their 
condition (Diabetes UK, 2019). Accepting the diagnosis can be a struggle, with the 
process being likened to the stages of grief for some individuals (Kubler-Ross, 1997). 
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Furthermore, learning and maintaining diabetes self-management behaviours, 
particularly during periods of life transitions, disease progression and/or onset of 
complications, can lead to people feeling overwhelmed and defeated (Young-Hyman 
et al., 2016). Approximately 45% of people experience diabetes-related psychological 
distress – sometimes called “diabetes burnout” – which can include feelings of anger, 
frustration and guilt specific to diabetes care, anxiety around having 
hypoglycaemia/hyperglycaemia and worrying about the risk of developing diabetes 
complications (Barnard et al., 2012; Nicolucci et al., 2013; Rane et al., 2011). The 
fact that diabetes can lead to complications despite good treatment adherence can not 
only be difficult to accept at times, but also bring up feelings about the futility of good 
self-management (McCracken et al., 2010).  Psychological difficulties have been 
linked to poorer diabetes self-management, impaired blood glucose control, reduced 
well-being, poorer quality of life and mortality (Eiser et al., 2001; Lustman & Clouse, 
2005; Rane et al., 2011). Depression alongside diabetes can have an additive effect on 
quality of life and has been linked with an increased risk of complications and disease 
burden (Moussavi et al., 2007). Increased feelings of burden can result in some 
individuals using unhelpful coping strategies, such as avoidance of self-management 
behaviours (Sturt et al., 2015). Having a frightening experience such as 
hypoglycaemia may also result in anxiety that increases self-management difficulties, 
as individuals may try to keep their blood glucose levels above their target range 
(Nash, 2014). This is important as poor psychological well-being may act as a barrier 
to reaching treatment goals, such as achieving optimal blood glucose levels and 
reducing the risk of complications (Sturt et al., 2015). Furthermore, these difficulties 
have a high economic impact as individuals with diabetes seeking physical treatment, 
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who experience mental health difficulties, can cost the NHS up to 50% more than 
those without mental health difficulties (Diabetes UK, 2019). 
Psychosocial interventions in diabetes  
With the increasing prevalence of diabetes and its associated public health 
burden, improving health outcomes for people with diabetes and implementing a 
holistic approach to diabetes care have been stressed as national priorities (NHS 
England, 2018). It is vital that people with diabetes have access to effective 
interventions that target psychological well-being and self-management in order to 
improve overall health outcomes and quality of life. 
A range of psychosocial interventions for adults with diabetes are used 
clinically to promote well-being, adaptive health beliefs as well as behavioural and 
lifestyle changes. These include education-based approaches, problem-solving 
approaches, support groups and more specific psychological interventions such as 
cognitive behavioural therapy (CBT), counselling, motivational interviewing and 
psychodynamic therapy (Harvey, 2015). A recently published meta-analysis found 
that diabetes-tailored psychological interventions significantly reduced diabetes-
related distress and HbA1c levels, a key measure of long-term glycaemic control, in 
both adults with T1D and T2D (Schmidt et al., 2018). However, other systematic 
reviews and meta-analyses in the field have identified a mixed evidence base with 
some studies suggesting that psychological interventions lead to improvements in 
HbA1c levels, diabetes self-care, depressive symptoms and quality of life in adults 
with T1D and T2D, whilst others partially or completely contradict these results 
(Chew et al., 2017; Pascoe et al., 2017; Steed et al., 2003; Thorpe et al., 2012; 
Winkley et al., 2020a; Winkley et al., 2020b). These inconsistent findings have been 
25 
 
suggested to be the result of various factors such as theoretical differences between 
psychological interventions, difficulty targeting multiple outcome factors (e.g. mental 
health and physical health), and inadequate focus on maintenance of self-management 
(Chew et al., 2018; Harkness et al., 2010). 
CBT is a widely used psychological approach which aims to alleviate distress 
by targeting maladaptive cognitions and behaviours through challenging cognitions 
and conducting behavioural experiments (Beck, 2011). It has been shown to 
effectively improve depression, anxiety, stress, self-efficacy, self-care behaviour, 
quality of life and fasting glucose levels in both adults with T1D and T2D, with mixed 
results for improving diabetes-related distress and blood glucose control (Harvey, 
2015; Li et al., 2017). Due to the accurate nature of thoughts and distress related to 
health conditions at certain times and situations, challenging these inner experiences 
can have limited effectiveness for some individuals as they are often linked to the 
possibility of realistic consequences (e.g. fear of having hypoglycaemia). In line with 
this dilemma, CBT has evolved over the last few decades and a “third wave” of CBT 
interventions emerged, which aims to target individuals’ relationships with their 
internal experiences rather than the content of these experiences (Hayes & Hofmann, 
2017). 
Acceptance and Commitment Therapy 
Acceptance and Commitment Therapy (ACT; Hayes et al., 1999) is one of the 
therapeutic approaches falling within “third wave” CBT that is increasingly being 
used clinically to support individuals with health conditions. In contrast to traditional 
CBT, ACT views distress as a normal human experience and moves away from 
attempts to reduce distress directly or to challenge or alter beliefs. Instead, it attempts 
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to reduce the influence of difficult internal experiences (thoughts, memories, feelings, 
etc.) on the individual’s behaviour. The main aim is to enable the individual to take 
meaningful action alongside difficult internal experiences (i.e., “I could lose a limb”). 
Experiential avoidance (attempts to avoid painful internal experiences and subsequent 
avoidant actions) and cognitive fusion (perceiving thoughts as absolute truths) are 
thought to be key unhelpful processes in ACT (Hayes et al., 1999). For example, 
cognitive fusion may lead individuals to view beliefs about their diabetes care as 
absolute truths, which may subsequently impact on their behaviour. Experiential 
avoidance may manifest as poor diabetes self-management when individuals avoid 
negative inner experiences about their diabetes, even when doing so causes harm. 
The aim of ACT is to enable individuals to cultivate an open, mindful, and 
accepting stance towards difficult internal experiences, and move towards engaging in 
value-based living. It achieves this through promoting psychological flexibility using 
a range of experiential methods, such as mindfulness exercises, exercises to connect 
with personal values, and thought defusion exercises (Hayes et al., 1999). The core 
components of psychological flexibility are illustrated in the “Hexaflex” model 
(Figure 1), which is made up of six interrelated processes: acceptance; cognitive 
defusion (i.e. the ability to separate ourselves from our thoughts and not get “fused” 
with them); contact with the present moment (i.e. being mindful); using the self as 
context; connecting to our values; and taking committed value-based action (Harris, 
2009; Hayes et al., 1999). 
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Figure 1  
ACT “Hexaflex” 
 
Note. Reprinted from “ACT made simple: An easy-to-read primer on acceptance and 
commitment therapy”, by Harris, R., 2009, p. 10, Oakland, CA: New Harbinger 
Publications, Inc. Copyright 2009 by New Harbinger Publications, Inc. 
 
Interest in ACT has risen over the years with an increasing number of 
randomised controlled trials and meta-analyses being conducted to establish its 
evidence base, given its popularity in clinical practice (Öst, 2014). For example, A-
Tjak and colleagues (2015) conducted a meta-analysis of 39 studies, observing that 
ACT was more beneficial than treatment-as-usual and control interventions, and as 
favourable as established psychological interventions, such as CBT, for conditions 
such as depression, anxiety disorders and substance misuse. ACT’s focus on 
acceptance and on living a meaningful life has particularly attracted attention in the 
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context of treating long-term conditions, with an emerging evidence base in chronic 
pain, tinnitus, cancer, epilepsy, cardiac disease, multiple sclerosis and diabetes 
(Graham et al., 2016; Hughes et al., 2017; Öst, 2014). 
Current review  
Due to the relative ease of applying ACT concepts to physical health 
conditions, ACT has been seen as a promising approach for improving the health 
outcomes for people with diabetes. It is increasingly being used in clinical practice 
following the publication of a randomised controlled trial (RCT) conducted by Gregg 
and colleagues (2007) which aimed to improve the diabetes self-management of 
adults with T2D and led to the publication of a diabetes-specific ACT treatment 
manual. This study generated interest into the use of ACT with the diabetes 
population internationally, with some of the emerging literature (six studies) captured 
by recently conducted systematic reviews into ACT for health conditions (Graham et 
al., 2016) and well-being interventions for individuals with diabetes (Massey et al., 
2019). 
However, a focussed systematic review of the evidence base of ACT in 
diabetes has not been conducted to date. Given the rapidly growing number of studies 
in this field, the review aimed to systematically describe the characteristics of ACT 
interventions for people with diabetes, and to examine whether ACT improves 
diabetes-related outcomes in both T1D and T2D, in order to increase current 
understanding of the evidence for the efficacy of ACT interventions and inform future 
research in this area. The research questions were: 
1) What are the characteristics of ACT interventions for people with diabetes? 
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2) To what extent does ACT improve (i) psychological, (ii) behavioural and (iii) 
physical outcomes in people with T1D? 
3) To what extent does ACT improve (i) psychological, (ii) behavioural and (iii) 
physical outcomes in people with T2D? 
Method 
Search strategy 
A systematic review protocol and search strategy were developed, guided by 
Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA; 
Moher et al., 2009) and guidance for undertaking reviews in healthcare published by 
the Centre for Reviews and Dissemination (CRD; 2009). The PICOS tool (CRD, 
2009) was used to develop research questions through identifying the specific 
components and concepts of interest. The review was registered on PROSPERO in 
advance (registration number: CRD42019150001). 
Search terms were developed using Boolean operators to capture the concepts 
of diabetes and ACT in line with the research questions. As initial scoping searches 
indicated that there was a small number of studies for review, a decision was made to 
exclude more specific search terms related to outcomes to reduce the number of 
search restrictions. The search term “ACT” was excluded due to retrieving an 
excessive number of citations (≈9400). The selected search terms were ‘(diabete* OR 
diabetic) AND ("acceptance and commitment therapy" OR “acceptance commitment 
therapy” OR “acceptance and commitment training”)’ based on search terms used by 
past relevant systematic reviews on diabetes and ACT, and verified by a librarian with 
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expertise in conducting systematic reviews at Royal Holloway, University of London 
(RHUL). 
Inclusion and exclusion criteria 
Studies were included in the review if they: (a) used a quantitative 
experimental or quasi-experimental research design; (b) recruited participants with 
T1D and/or T2D; (c) investigated any form of ACT-based intervention(s) (individual, 
group or online), which incorporated both components of acceptance and committed 
action to capture key processes within the model that increase psychological 
flexibility (Hayes et al., 1999); and (d) measured psychological, behavioural or 
physical diabetes-related outcome(s) using standardised tools (see Appendix A for full 
eligibility criteria). 
Study selection 
Three databases were searched on 15th September 2019 via the RHUL library: 
PubMed, Web of Science Core Collection (1970-present) and PsycINFO (interface: 
EBSCOhost Research Databases). The “Advanced Search” option was used in all 
searches with no restrictions on language and publication date. PubMed and Web of 
Science Core Collection were searched “in all fields”, and PsycINFO was searched 
“in all text”. All search results were exported to the reference management software, 
Zotero, and duplicates of studies were removed. 
To minimise publication bias, hand-searches were conducted in the following 
locations to identify further eligible studies for the review: research registers such as 
ClinicalTrials.gov and World Health Organisation International Clinical Trials 
Registry Platform; databases of unpublished dissertations, theses and reports, such as 
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OpenGrey, ProQuest Dissertations & Thesis Global, Health Sciences Online 
Libraries, WHO Global Health Library, NICE Evidence, World Wide Science, 
PsycEXTRA, York Health Economics Consortium, Cochrane Library and Google 
Scholar; the publications list on the Association of Contextual Behavioural Science 
website (contextualScience.org); and Dr. Steven C. Hayes’ (a leading researcher and 
developer of ACT) publications list (www.stevenchayes.com/literature/publications). 
Experts in the field, Dr. Steven C. Hayes and Dr. Jennifer A. Gregg (a researcher and 
developer of the ACT for diabetes self-management manual), were contacted via e-
mail to establish whether they were aware of any further relevant studies; no 
additional studies were identified from their responses. 
Two reviewers independently completed a title and abstract screen, which 
excluded any records that did not fulfil the inclusion criteria. Full-text papers of 
eligible studies were then screened independently by both reviewers against the 
inclusion and exclusion criteria. Any disagreements over eligibility were resolved 
through discussion. A reference list search of all eligible articles was completed to 
identify any final eligible studies to include in the review. 
Assessment of risk of bias 
The Effective Public Health Practice Project (EPHPP; 1998) Quality 
Assessment Tool for Quantitative Studies was used to assess the quality of the eligible 
studies. The EPHPP was chosen because it was specifically developed to evaluate 
public health interventions and has demonstrated good validity and reliability 
properties (Thomas et al., 2004). The following study components were rated using a 
three-point scale (“weak”, “moderate” and “strong”): selection bias; study design; 
confounders; blinding; data collection methods; withdrawals or drop-outs; 
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intervention integrity; and analysis. A global quality rating was calculated based on 
the overall number of study components that were assessed as “weak”. A quality 
assessment of each eligible study was independently carried out by the primary 
reviewer and 20% of the studies were assessed by a second reviewer to check for 
consistency (percentage agreement = 87.5%, κ = .80). Disagreements over quality 
ratings were resolved through discussion. The quality appraisal was not used to 
exclude any studies, but to inform the narrative synthesis in line with standard 
practice (CRD, 2009). 
Data extraction 
Data from each study was independently extracted by the primary researcher 
and 10% of the data extraction was checked by a second reviewer for consistency. 
Where data were missing or unclear, authors were contacted via e-mail for further 
information, after which any remaining missing or unclear data was marked as such. 
The extracted information included: (a) publication details, including first 
author, year of publication, journal or source, publication status, country of study; (b) 
study characteristics, including study design, study methodology, study setting, aims 
and/or research questions, inclusion and exclusion criteria, number of trial arms, type 
of comparator(s), study duration, recruitment details, total number of participants 
randomised, number allocated to each trial arm, number in each trial arm at follow-up, 
and study completion rates; (c) participant characteristics, including  sample size, age 
(mean and range), gender (% female), study population and clinical diagnosis; (d) 
intervention and comparator and/or control characteristics, including descriptions of 
intervention, format, duration and intensity of delivery, delivery provider (e.g. detail 
of individual, discipline, level of training in delivering ACT), total intervention 
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duration, control condition, and details of ACT processes and techniques; (e) 
effectiveness of intervention, including details of primary outcome measure and 
secondary outcome measures, measurement method, time points for data collection, 
effect sizes at post-intervention and follow-up and author’s conclusions; and (f) risk 
of bias, indicated by the quality assessment outcome. 
Data synthesis 
A narrative synthesis of quantitative study findings was completed based on 
guidance from the CRD (2009) and reported in accordance with the PRISMA 
checklist. Differences in mean values, intervention effect sizes and statistical 
significance for all psychological, behavioural and physical diabetes-related outcomes 
were examined, where reported. To facilitate comparison between studies, effect sizes 
were computed based on available information. For studies using a single-group 
design, effect sizes were calculated by dividing the difference between pre- and post-
test means by the pre-test standard deviation (Hojat & Xu, 2004). For studies using 
experimental and control groups, effect sizes were calculated by dividing the 
difference between pre- and post-test mean changes of both groups by the pooled pre-
test standard deviation (Morris, 2008). All effect sizes were adjusted using a small 
sample size bias correction to obtain g (Hedges, 1981). 
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Records excluded  
(n = 65) 
Full-text articles assessed 
for eligibility  
(n = 22) 
Full-text articles excluded: 
- Qualitative design (n = 1) 
- Non-ACT-based 
intervention (n = 2) 
- Duplication of same 
material in different 
publications (n = 2) 
- No access to results (n = 1) 
Duplicates removed  
(n = 37) 
Titles and abstracts screened  
(n = 87) 
Records identified through 
database searching  
(n = 117) 
Additional records identified 
through other sources  
(n = 7) 
Studies assessed as eligible 
for narrative synthesis 
(n = 16) 
Additional articles identified 
through reference lists  
(n = 1) 
Studies included in narrative 
synthesis 
(n = 17) 
Figure 2  
PRISMA Flowchart of the Systematic Review 
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Results 
Description of studies 
The study selection process is depicted in Figure 2. Overall, 117 citations were 
retrieved from PubMed (n = 48), PsycINFO (n = 38) and Web of Science (n = 31). 
The grey literature search identified seven additional records. Following the removal 
of 37 duplicates of studies, a title and abstract screen of 87 records was completed, 
out of which 65 records were excluded from the review (percentage agreement = 
100%; κ = 1) due to either not fulfilling criteria related to research design (n = 37), 
participant characteristics (n = 36) and/or intervention type (n = 28). Twenty-two full-
text papers of eligible studies were screened (percentage agreement = 89.5%; κ = 1). 
Reasons for excluding studies included: incorrect research design (n = 1); incorrect 
intervention type (n = 2); and no access to results (n = 1). Two articles were also 
excluded as they were duplicates of the same studies in different publications. Two 
disagreements over eligibility were resolved through discussion. Sixteen articles were 
assessed as eligible for the review, and one additional article was found following 
reference list searches of all eligible articles, resulting in a total of 17 studies included 
for narrative synthesis. Table 1 summarises the characteristics of the studies, 
categorised by clinical diagnosis (T1D, T2D, and combined diabetes types).
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Table 1 
Study Characteristics 
First author, year 
Country 
Sample characteristics Study design Intervention details 
Study 
completion 
rate 
Type 1 diabetes     
Lehikoinen, 2018 
 
Finland 
 
 
N = 32 
 
a 68.8% Female 
 
Age: M = 13.7, SD = 1.38, range 
= 12-16 
 
Adolescents with T1D whose 
HbA1c > 7.5%, recruited from 
paediatric outpatient clinic with 
parents 
 
Pre-test, post-test 
experimental design 
 
Experimental group: 
ACT and treatment-
as-usual (n = 16) 
 
Control group: 
Treatment-as-usual 
(n = 16) 
Format: ACT-based group programme including 
discussion, exercises and voluntary homework between 
sessions. 
 
Components: behavioural analysis; values clarification; 
value-based actions; setting realistic goals; mindfulness; 
cognitive defusion; acceptance; using self-as-context 
 
Duration: five sessions lasting 1.5 hours each, held 
fortnightly (10 weeks in total) 
 
Delivery provider: a psychologist and psychology 
students 
 
25/32; 
a 78.1% 
Type 2 diabetes     
Ahmadsaraei, 2017 
 
Iran 
N = 40 
 
a 67.5% Female 
 
Age (experimental group): M = 
44.1, SD = 6.77, range = NR 
Age (control group): M = 43.0, 
SD = 4.05, range = NR 
 
Pre-test, post-test, 
follow-up quasi-
experimental design 
 
Experimental group: 
ACT (n = 20) 
 
Control group: 
Pre-test-post-test 
only (n = 20) 
Format: ACT-based group programme 
 
Components: creative hopelessness; values clarification 
and connection; cognitive defusion; mindfulness; 
committed action; review 
 
Duration: eight sessions lasting 1.5 hours (length NR; 3-
month follow-up) 
 
Delivery provider: NR 
NR 
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First author, year 
Country 
Sample characteristics Study design Intervention details 
Study 
completion 
rate 
Adults diagnosed with T2D for ≥5 
years with a BDI score of 29-63, 
referred by a local diabetes 
association 
 
  
Amirfakhraei, 2016 
 
Iran 
N = 80 
 
50% Female 
 
Age: M = NR, SD = NR, range = 
29-52 
 
Married adults with T2D, 
recruited from counselling centres 
and other related institutes in 
Bandar Abbas 
 
 
Solomon four-group 
quasi-experimental 
design 
 
Experimental group: 
Pre-test-post-test 
ACT (n = 20) 
Post-test only ACT 
(n = 20) 
 
Control group: 
Pre-test-post-test 
only (n = 20) 
Post-test only (n = 
20) 
 
Format: ACT-based group couples therapy workshop 
 
Components: creative hopelessness; acceptance; contact 
with present moment; cognitive defusion; values 
clarification; setting goals 
 
Duration: eight sessions lasting 1.5 hours each, held 
weekly (eight weeks in total) 
 
Delivery provider: NR 
NR 
Fayazbakhsh, 2019 
 
Iran 
N = 24 
 
a 20.8% Female 
 
Age (experimental group): M = 
50.4, SD = 10.3, range = NR 
Age (control group): M = 42.4, 
SD = 10.0, range = NR 
 
Pre-test, post-test 
quasi-experimental 
design 
 
Experimental group: 
ACT (n = 12) 
 
Control group: 
Pre-test-post-test 
only (n = 12) 
Format: NR 
 
Components: NR 
 
Duration: eight sessions lasting 1.5 hours each (length 
NR) 
 
Delivery provider: NR 
NR 
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First author, year 
Country 
Sample characteristics Study design Intervention details 
Study 
completion 
rate 
Patients with T2D, recruited 
through convenience sampling 
from the Iranian Diabetes Society 
 
Ghasemlou, 2018 
 
Iran 
N = 30 
 
100% Female 
 
Age: M = NR, SD = NR, range = 
35-45 
 
Women aged 20-45 with T2D, 
recruited through convenience 
sampling from a specialist 
medical diagnostic laboratory 
 
Pre-test, post-test 
quasi-experimental 
design 
 
Experimental group: 
ACT (n = 12) 
 
Control group: 
Pre-test-post-test 
only (n = 13) 
Format: ACT-based group counselling using group 
exercises based on protocol by Eifert & Forsyth (2005) 
 
Components: identifying experiential avoidance; 
creative hopelessness; cognitive defusion; using self-as-
context; mindfulness; contact with the present moment; 
values clarification; valued action; distinguishing values 
from goals; addressing barriers; feedback 
 
Duration: 15 sessions lasting 1.5 hours each (length NR) 
 
Delivery provider: NR 
 
NR; 
a 83.3% 
Gregg, 2007  
 
USA 
N = 81 
 
46.9% Female 
 
Age (experimental group): M = 
51.9, SD = NR, range = NR 
Age (control group): M = 49.8, 
SD = NR, range = NR 
 
Adults with T2D, receiving 
medical care at a low-income 
primary healthcare clinic and 
referred by their primary care 
provider 
RCT with pre-test 
and follow-up 
 
Experimental group: 
ACT and education 
(n = 43) 
 
Control group: 
Education only (n = 
38) 
Format: Education and ACT-based group workshop 
including mindfulness and acceptance training 
 
b Components: psychoeducation; behavioural analysis; 
mindfulness; acceptance; values exploration and 
clarification; value-based action; setting goals; 
addressing barriers; cognitive defusion; acceptance 
 
Duration: One session lasting seven hours (one day in 
total with 3-month follow-up) 
 
Delivery provider: First author, b a clinical psychology 
doctoral student trained and experienced in delivering 
ACT 
 
73/81; 
a 90.1% 
39 
 
First author, year 
Country 
Sample characteristics Study design Intervention details 
Study 
completion 
rate 
Hor, 2014 
 
Iran 
N = 30 
 
% Female NR 
 
Age (experimental group): M = 
49, SD = NR, range = NR 
Age (control group): M = 47.5, 
SD = NR, range = NR 
 
Adults diagnosed with T2D by an 
“internist” and depression by the 
researcher using DSM-IV-TR and 
a BDI score cut-off of >16, 
recruited from a diabetes charity 
institution 
 
Pre-test, post-test, 
follow-up quasi-
experimental design 
 
Experimental group: 
ACT (n = 15) 
 
Control group: 
Waitlist control (n = 
15) 
Format: ACT-based group therapy using exercises and 
metaphors 
 
Components: creative hopelessness; cognitive defusion; 
using self-as-context; observer self; mindfulness; values 
exploration and valued actions 
 
Duration: eight sessions lasting two hours each (length 
NR; follow-up length NR) 
 
Delivery provider: NR 
100% 
Kaboudi, 2017 
 
Iran 
N = 26 
 
100% Female 
 
Age: M = NR, SD = NR, range = 
25-65 
 
Women with T2D, referred to a 
specialist clinic and recruited 
through convenience sampling 
 
Pre-test, post-test 
quasi-experimental 
design 
 
Experimental group: 
ACT (n = 13) 
 
Control group: 
Pre-test-post-test 
only (n = 13) 
Format: ACT-based training sessions 
 
Components: creative hopelessness; values clarification; 
cognitive defusion; mindfulness; committed valued 
action; using self-as-context; review; plan forward 
 
Duration: eight sessions lasting 1.5 hours each (length 
NR) 
 
Delivery provider: NR 
 
NR 
Khashouei, 2016 
 
Iran 
N = 32 
 
100% Female 
 
Pre-test, post-test, 
follow-up quasi-
experimental design 
 
Format: NR 
 
Components: NR 
 
NR 
40 
 
First author, year 
Country 
Sample characteristics Study design Intervention details 
Study 
completion 
rate 
Age (experimental group): M = 
47.2, SD = 8.84, range = NR 
Age (experimental group): M = 
49.6, SD = 9.02, range = NR 
 
Women aged 30-50 with T2D, 
recruited through convenience 
sampling of those referred to an 
endocrine and metabolism 
research centre 
 
Experimental group: 
ACT (n = 16) 
 
Control group: 
Pre-test-post-test 
only (n = 16); Four 
ACT sessions offered 
after study 
completion - not 
analysed 
Duration: eight sessions lasting 1.5 hours each, held 
weekly (eight weeks; three-month follow-up) 
 
Delivery provider: NR 
 
 
Nes, 2012 
 
Norway 
N = 15 
 
a 33.3% Female 
 
Age: M = 59.6, SD = NR, range = 
46-71 
 
Adults with T2D, recruited 
through two general practices and 
the social networks of researchers 
 
Pre-test, post-test 
single-group design 
 
Experimental group: 
ACT (n = 11) 
Format: Online via smartphone with feedback, 
stimulation of reflections 
 
Components: values clarification and connection; 
encouraging value-based behaviour; differences between 
values and goals; setting goals; addressing barriers; 
psychoeducation; awareness; acceptance and willingness 
 
Duration: three daily online diary entries (three months 
in total) 
 
Delivery provider: A nurse trained in ACT 
 
11/15; 
a 73% 
NHS Grampian, 
2015 
 
Scotland 
N = 35 
 
a 43% Female 
 
Age: M = 63.7, SD = 9.8, range = 
NR 
 
Pre-test, post-test, 
follow-up single-
group design 
 
Experimental group: 
ACT (n = 27) 
Format: ACT-based, guided self-help programme with 
individual face-to-face appointments and web-based 
modules 
 
Components: psychoeducation; behavioural analysis; 
values clarification; value-based actions; addressing 
barriers; relapse management; plan forward 
 
77.1% 
41 
 
First author, year 
Country 
Sample characteristics Study design Intervention details 
Study 
completion 
rate 
Adults with T2D, whose 
glycaemic control was among the 
poorest 40% in Grampian area (≥ 
61 mmol/mol), recruited through 
self-referral from five general 
practices and a secondary care 
diabetes clinic 
 
Duration: five to eight sessions (length NR; 3-month 
follow-up) 
 
Delivery provider: a trainee health psychologist and a 
psychological well-being practitioner 
 
Shayeghian, 2016 
 
Iran 
N = 106 
 
60% Female 
 
Age: M = 55.4, SD = 8.44, range 
= NR 
 
Adults aged between 40-60 with 
T2D diagnosed within last 1±10 
years, recruited through 
convenience sampling using 
referrals from an endocrinologist 
 
RCT with follow-up 
 
Experimental group: 
ACT and education 
(n = 53) 
 
Control group: 
One-day education 
workshop (n = 53) 
Format: Education and group-based ACT workshop with 
exposure-based and experiential exercises and 
mindfulness training 
 
Components: NR; based on Gregg’s (2004) ACT 
protocol  
 
Duration: 10 weekly sessions (10 weeks in total; 3-
month follow-up) 
 
Delivery provider: NR 
 
100/106; 
a 94.4% 
Welch, 2014 
 
USA 
N = 31 
 
70% Female 
 
Age: M = 43.0, SD = 9.09, range 
= 32-53 
 
Adults with T2D diagnosed for ≤2 
years, displaying distress 
identified by a score of >3 in 
regimen distress and/or emotional 
Pre-test, post-test 
single-group design 
 
Experimental group: 
ACT (n = 20) 
Format: ACT-based group workshop split into four 
modules, with published ACT and mindfulness exercises 
followed by discussion points 
 
Components: contact with present moment; mindfulness; 
values clarification and connection; behaviour analysis; 
identifying barriers; cognitive defusion; commitment to 
action; creative hopelessness; acceptance; review and 
relapse management 
 
20/31; 
a 64.5% 
42 
 
First author, year 
Country 
Sample characteristics Study design Intervention details 
Study 
completion 
rate 
burden subscales of DDS17, 
recruited from online diabetes 
associations and online public 
domains through convenience 
sampling 
 
Duration: eight hours (one day in total; post-test 
measures obtained two weeks after workshop 
completion) 
 
Delivery provider: First author 
Whitehead, 2017 
 
New Zealand 
N = 157 
 
a 46.6% Female 
 
Age (ACT and education group): 
M = 56.1, SD = 6.91, range = NR 
Age (Education group): M = 53.8, 
SD = 8.68, range = NR 
Age (Control group): M = 56.4, 
SD = 6.97, range = NR 
 
Adults with T2D with suboptimal 
glycaemic control (HbA1c >7% or 
>53mmol/mol) for ≥1 year, 
recruited using adverts on radio, 
community newsletters and 
newspapers as well as letters sent 
to eligible patients by medical 
centres in one city 
 
RCT with follow-up 
 
Experimental groups: 
ACT and education 
(n = 39) 
Education (n = 26) 
 
Control group: 
Routine care (n = 41) 
Format: Group workshop incorporating ACT and 
psychoeducation, supplemented with workbook and 
slide presentation 
 
Components: mindfulness; acceptance; values 
clarification; value-based actions (material drawn from 
Gregg et al., 2007) 
 
Duration: 6.5 hours (one day in total; six-month follow-
up) 
 
Delivery provider: Mental health nurse with expertise in 
ACT and supervised by a clinical psychologist 
106/157; 
a 75.1% 
Type 1 and 2 diabetes    
Moazzezi, 2015 
 
Iran 
N = 40 
 
a 30.6% Female 
 
Pre-test, post-test 
controlled clinical 
trial 
 
Format: ACT-based group therapy including exercises 
 
Components: functional analysis; creative hopelessness; 
values clarification; building commitment; acceptance; 
36/40; 
a 90% 
43 
 
First author, year 
Country 
Sample characteristics Study design Intervention details 
Study 
completion 
rate 
Age (Experimental group): M = 
11.4, SD = 2.59, range = NR 
Age (Control group): M = 9.72, 
SD = 2.37, range = NR 
 
Children aged 7-15 with T1D or 
T2D for ≤1 year, recruited 
through convenience sampling of 
people referred to a local diabetes 
association 
 
Experimental group: 
ACT (n = 18) 
 
Control group: 
Pre-test-post-test 
only (n = 18) 
cognitive defusion; using self-as-context; addressing 
barriers; relapse prevention  
 
Duration: 10 sessions lasting 1.5 hours, held weekly (10 
weeks in total) 
 
Delivery provider: NR 
Moghanloo, 2015 
 
Iran 
N = 40 
 
a 50% Female 
 
Age (Experimental group): M = 
10.4, SD = 2.91, range = NR 
Age (Control group): M = 10.6, 
SD = 3.16, range = NR 
 
Children aged 7-15 with T1D (n = 
19) or T2D (n = 15) for ≤1 year, 
recruited through convenience 
sampling of people referred to a 
local diabetes association 
 
Pre-test, post-test 
controlled clinical 
trial 
 
Experimental group: 
ACT (n = 17) 
 
Control group: 
Pre-test-post-test 
only (n = 17) 
Format: ACT-based group therapy including exercises 
 
Components: functional analysis; creative hopelessness; 
values clarification; building commitment; acceptance; 
cognitive defusion; using self-as-context; addressing 
barriers; relapse prevention  
 
Duration: 10 sessions lasting 1.5 hours, held weekly (10 
weeks in total) 
 
Delivery provider: A psychologist (different 
psychologist obtained outcome measures) 
34/40; 
a 85% 
Ryan, 2019 
 
Australia 
N = 28 
 
70% Female 
 
Age: M = 54.0, SD = 12.8, range 
= 24-74 
Pre-test, post-test 
single-group design 
 
Experimental group: 
ACT (n = 20) 
Format: “READY” an ACT-based group programme 
with 10 modules, including a workbook, exercises, 
reflections, review of key learning points and between-
session personalised tasks 
 
a 71.4% 
44 
 
First author, year 
Country 
Sample characteristics Study design Intervention details 
Study 
completion 
rate 
 
Adults with self-reported T1D 
(30%) or T2D (70%), recruited 
via Diabetes Australia and 
university staff e-newsletters, a 
radio interview, and flyers 
distributed through General 
Practitioners, pharmacies and a 
diabetes clinic 
 
Components: psychoeducation; focus on resilience; 
mindfulness; experiential avoidance; acceptance; 
cognitive defusion; addressing barriers / troubleshooting; 
self-as-context; physical activity planning; values 
clarification and connection; setting realistic goals; 
relaxation; social connectedness; review and future 
planning 
 
Duration: 10 sessions (eight 2-hour sessions and two 1-
hour sessions) (10 weeks in total) 
 
Delivery provider: a postgraduate clinical psychology 
student with formal ACT training, supervised fortnightly 
 
 
Note. a Calculated based on information in full-text paper; b Information supplemented using Gregg’s (2004) dissertation 
Key. ACT = Acceptance and Commitment Therapy; BDI = Beck Depression Inventory; DDS17 = Diabetes Distress Scale; DSM-IV-TR = 
Diagnostic and Statistical Manual of Mental Disorders – 4th Edition – Text Revision; HbA1c = glycated haemoglobin; NR = not reported; RCT = 
randomised controlled trial; T1D = type 1 diabetes; T2D = type 2 diabetes. 
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Study characteristics 
The year of publication of the studies ranged between 2007 and 2019. In total, 14 
peer-reviewed journal articles, two unpublished theses and one report were included in the 
review. The studies were based in a variety of countries including Iran (10 studies), USA 
(two studies), Finland (one study), Norway (one study), Scotland (one study), Australia (one 
study) and New Zealand (one study). The employed study designs included: RCTs (three 
studies); pre-test-post-test experimental design (three studies); Solomon four-group quasi-
experimental design (one study); pre-test-post-test quasi-experimental design (six studies); 
and pre-test-post-test single group design (four studies). All studies included pre- and post-
intervention outcome measures, and six studies included follow-up measurements, which 
were either three months (four studies), six months (one study) or not reported (one study). 
Four studies used an intervention condition only. A control/comparison condition was used in 
13 studies, of which eight studies used a pre-test-post-test measurements only control 
condition, two studies used routine care or treatment-as-usual, one study used a waitlist 
control condition, and two studies used an active control condition based on education. The 
study completion rate was not reported by five studies. Of the 12 studies that reported figures, 
the completion rate ranged from 64.5% to 100%, with a mean rate of 81.8%.  
The studies investigated a range of psychological, behavioural and physical health 
outcomes. Six studies measured physical outcomes such as glycated haemoglobin (HbA1c), 
fasting blood glucose and cholesterol levels using blood tests. Six studies examined 
behavioural outcomes, which included diabetes self-management and level of physical 
activity. These were primarily measured using self-report questionnaires with the exception 
of outcomes such as weekly step count, which were measured using smart devices. All 
studies examined at least one psychological outcome and at least 20 different psychological 
outcomes were measured across all studies using self-report questionnaires. General 
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psychological outcomes included depression, anxiety, stress, quality of life, coping, self-
efficacy, resilience, psychological well-being, guilt, marital satisfaction and positive 
emotions. Diabetes-specific psychological outcomes included diabetes-related distress, 
understanding of diabetes and diabetes self-management, and diabetes-related quality of life. 
A variety of ACT process outcomes were also measured by seven studies using self-report 
questionnaires, such as diabetes acceptance, psychological flexibility, experiential and 
emotional avoidance, frequency of automatic negative thoughts, negative thought 
suppression, mindfulness and valued living. 
Participant characteristics 
The total number of participants from all included studies was 827, with sample sizes 
ranging between 15 and 157. Fourteen studies investigated adult populations with ages 
ranging between 18 and 65, and three studies investigated paediatric populations with ages 
ranging between seven and 15. One study did not report participants’ gender; across the 
remaining 16 studies, 59.8% cases were female, with two studies investigating women only. 
A range of ethnicities was captured by the studies, although at least half of the cases were 
likely Iranian. Thirteen studies solely recruited adults diagnosed with T2D and one study 
solely recruited people with T1D. Three studies focused on people with either diagnosis, 
from which one study did not report the diagnosis ratio and two studies reported that 70% and 
44.1% of the participants had T2D. The criteria for meeting the diagnosis of diabetes was not 
reported in 13 studies, other than the participants were recruited from specialist diabetes 
clinics and organisations. Diagnosis of diabetes was determined by self-report in one study 
and confirmed by a physician or via clinical examination in three studies. Only six studies 
reported on mean duration of diabetes and three studies reported mean HbA1c values, 
precluding the calculation of mean values for these factors. 
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With regards to sampling method, 12 studies used convenience sampling relying on 
self-referrals from participants, two studies selected participants based on their HbA1c cut-off 
criteria (>7.5% and ≥61mmol/mol), two studies selected participants based on their Beck 
Depression Inventory score cut-off criteria (>16 in one study, and between 29 and 63 in the 
other) and one study recruited participants based on referrals from their care provider. In 
terms of recruitment criteria, three studies specifically targeted people with poor glycaemic 
control, two studies targeted people experiencing depression, one study targeted people 
displaying distress, one study specifically selected married people and one study selected 
people from a low-income primary healthcare clinic. 
Characteristics of ACT interventions 
All interventions were ACT-based as their primary theoretical framework. The studies 
had a variety of aims such as: to develop a feasible ACT-based intervention for the target 
diabetes population, to investigate the effectiveness of ACT in improving outcome(s) of 
interest, and/or to examine the role of potential moderators and mediators. 
Of the 17 interventions examined, 13 interventions were described as group 
programmes or workshops, one study used an online programme, one study combined 
individual face-to-face work with an online module, and two studies did not report on 
intervention format. The number of sessions varied from one to 15 sessions, with the majority 
of the interventions lasting between eight and 10 sessions (10 studies). Three studies included 
a one-off day-long intervention. Sessions ran weekly in six studies and fortnightly in one 
study. One study required participants to take part in an online intervention three times daily, 
and five studies did not report the frequency of sessions. The length of the sessions varied 
between 1.5 hours (most common) and eight hours (in the case of one-off workshops). The 
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total intervention length varied from one day to three months, with six studies not reporting 
this figure.  
Commonly reported components were the use of behavioural or functional analysis, 
ACT-specific psychoeducation (e.g. on creative hopelessness and experiential avoidance), 
mindfulness, contact with the present moment, cognitive defusion, acceptance, self-as-
context, values clarification and connection, setting and making a commitment to work 
towards value-based goals, addressing barriers, review and future planning, in line with the 
core components of psychological flexibility. Some interventions also had additional 
components such as promoting diabetes education, resilience, relaxation, and social 
connectedness. 
Only eight out of 17 studies reported information on the intervention delivery 
providers. Delivery providers included a psychologist (one study), a psychologist and their 
students (one study), a postgraduate/doctoral student with ACT training (two studies), a nurse 
trained in ACT (one study), a trainee health psychologist and psychological well-being 
practitioner (one study) and a doctoral student (one study). Only two studies provided 
information on assessing treatment fidelity, which included reviewing treatment adherence 
against the protocol, manual and/or study-specific coding system. 
Risk of bias within studies 
Quality ratings of each study are summarised in Table 2. The overall quality of the 
studies was poor, with 13 studies obtaining a “weak” quality rating, three studies obtaining a 
“moderate” quality rating and one study obtaining a “strong” rating. Areas of strength were 
identified in study designs (13 studies), control of confounders (13 studies) and data 
collection methods (17 studies). Common weaknesses were: not providing information on 
blinding procedures (14 studies); using convenience sampling and not providing information 
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on percentage of participants agreeing to participate, increasing the likelihood of selection 
bias (13 studies); and not reporting withdrawals and dropouts (six studies). 
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Table 2 
Quality Ratings of Included Studies 
 
Note. Overall quality rating: Strong = 0 weak ratings; Moderate = 1 weak rating; Weak = ≥2 weak ratings 
First Author, Year 
Selection 
bias 
Study design Confounders Blinding 
Data collection 
method 
Withdrawals 
and dropouts 
Overall quality 
rating 
Type 1 diabetes 
Lehikoinen, 2018 Moderate Strong Weak Weak Strong Moderate Weak 
Type 2 diabetes 
Ahmadsaraei, 2017 Moderate Strong Strong Weak Strong Weak Weak 
Amirfakhraei, 2016 Weak Strong Strong Weak Strong Weak Weak 
Fayazbakhsh, 2019 Weak Strong Strong Weak Strong Weak Weak 
Ghasemlou, 2018 Weak Strong Strong Weak Strong Weak Weak 
Gregg, 2007 Moderate Strong Strong Moderate Strong Strong Strong 
Hor, 2014 Weak Strong Weak Weak Strong Strong Weak 
Kaboudi, 2017 Weak Strong Weak Weak Strong Weak Weak 
Khashouei, 2016 Weak Strong Strong Weak Strong Weak Weak 
Nes, 2012 Weak Moderate Strong Weak Strong Moderate Weak 
NHS Grampian, 2015 Moderate Moderate Strong Weak Strong Moderate Moderate 
Shayeghian, 2016 Weak Strong Strong Weak Strong Strong Weak 
Welch, 2014 Weak Moderate Strong Weak Strong Strong Weak 
Whitehead, 2017 Weak Strong Strong Moderate Strong Moderate Moderate 
Type 1 and 2 diabetes 
Moazzezi, 2015 Weak Strong Weak Weak Strong Strong Weak 
Moghanloo, 2015 Weak Strong Strong Moderate Strong Strong Moderate 
Ryan, 2019 Weak Moderate Strong Weak Strong Moderate Weak 
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Table 3  
Main Results of Included Studies: The Impact of ACT on Psychological, Behavioural, Physical and Process Outcome Measures 
First Author, Year Outcomes (Measures) 
Main intervention findings 
(reported p and ES, and calculated g) 
Type 1 diabetes   
Lehikoinen, 2018 Psychological: 
 Depressive and anxiety symptoms (RBDI) 
 
Physical: 
 Glycaemic control (HbA1c) 
 
Process: 
 General level of psychological flexibility and 
mindfulness (CAMM) 
 Diabetes-specific psychological flexibility and 
ability to manage diabetes (DAAS) 
 
Significant treatment effect compared to control for DAAS between 
pre- and post-treatment (p < .05; r = .54; b g = .41) 
 
No significant treatment effect (p > .05) relative to controls for 
anxiety (r = .23; b g = .36), depression (r = .24; b g = .21), CAMM (r 
= .08; b g = .10) and HbA1c (r = .38; b g = .79) between pre- and 
post-treatment 
Type 2 diabetes   
Ahmadsaraei, 2017 Psychological: 
 Depression (BDI) 
 
Significant treatment effect over time relative to controls for 
depression (p < .001, d = .22) with a significant difference found 
between pre- and post-treatment (p < .001; b g = 1.04) and no 
significant differences between post-treatment and follow-up (p = 
.51) 
 
Amirfakhraei, 2016 Psychological: 
 Marital satisfaction and dysfunctional 
communicative attitude (RBQ) 
 
Overall significant treatment effect found relative to controls for 
marital satisfaction and dysfunctional communicative attitude (p < 
.01, η2 = .502) with significant treatment effects identified in those 
who completed pre-tests (p < .01, ES = .90; b g = 7.14) as well as 
those who did not (p < .01, ES = .96) 
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First Author, Year Outcomes (Measures) 
Main intervention findings 
(reported p and ES, and calculated g) 
Fayazbakhsh, 2019 Psychological: 
 Symptoms of Generalised Anxiety Disorder  
(GAD-7) 
 Worry (PSWQ) 
 Intolerance of uncertainty (IUS) 
 
Process: 
 Experiential avoidance (AAQ-II) 
 
Significant treatment effects found relative to controls for 
symptoms of GAD (p < .001, η2 = .73; b g = 1.16), worry (p < .001, 
η2 = .67; b g = 1.36), intolerance of uncertainty (p < .001, η2 = .60; b 
g = 1.52) and experiential avoidance (p < .001, η2 = .69; b g = 1.06) 
between pre- and post-treatment 
Ghasemlou, 2018 Psychological: 
 Anxiety symptoms (DASS) 
 Quality of life (SF-36) 
 
Significant treatment effects relative to controls with improvements 
observed in between pre- and post-test anxiety symptoms (p < .05, 
η2 = .17; b g = .79) and quality of life (p < .05, η2 = .51; b g = .83) 
 
Gregg, 2007 Psychological: 
 Understanding of diabetes (subscale of DCP) 
 a Coping – emotional expression and processing 
(EACS) 
 a Mental health-related quality of life (SF-36) 
 
Behavioural: 
 Self-management (questionnaire devised for study) 
 
Physical: 
 Glycaemic control (HbA1c and number of people 
with diabetic control) 
 
Process: 
 Acceptance of diabetes-related thoughts and 
feelings (AADQ) 
 a Frequency of automatic negative thoughts about 
self (ATQ) 
 a Negative thought suppression (WBSI) 
 a Emotional avoidance (AAQ) 
 
Significant treatment effect compared to controls at follow-up for 
diabetes-specific acceptance (p < .05,  ηp2 = .12), self-management 
(p < .05, ηp2 = .07; b g = .59; a when pre-test scores are controlled) 
and diabetic control status (p < .01, ηp2 = .08; a p <.05) 
 
No significant pre-post differences found in understanding of 
diabetes at follow-up (p = .16, ηp2 = .03;  a p = .252) 
 
Non-significant positive trend found for HbA1c compared to 
controls at follow-up (p = .081, ηp2 = .04; b g = .66) 
 
a No significant differences in thought suppression, emotional 
avoidance, coping, frequency and believability of automatic 
negative thoughts compared to controls at follow-up (p > .05) 
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First Author, Year Outcomes (Measures) 
Main intervention findings 
(reported p and ES, and calculated g) 
Hor, 2014 Psychological: 
 Depression (BDI-II) 
 
Significant improvements compared to controls were found 
between pre-test and post-test depression scores (p <.001, ES = 
.432; b g = 1.25) and between pre-test and follow-up depression 
scores (p <.001, ES = .677; b g = 1.57)  
 
Kaboudi, 2017 Psychological: 
 Mental health (GHQ-28) 
 
Significant treatment effect relative to controls for mental health at 
post-test (p = .001, η2 = .91; b g = 3.26)  
Khashouei, 2016 Psychological: 
 Self-efficacy (SES) 
 Perceived stress (PSS) 
 Resiliency (CDRS) 
Significant treatment effects (p < .05) observed relative to controls 
for self-efficacy at post-test (η2 = .43; b g = .76) and at a 3-month 
follow-up (η2 = .14; b g = .13), and for perceived stress at post-test 
(η2 = .17; b g = 1.37) and at follow-up (η2 = .23; b g = 2.81). No 
significant difference in resilience relative to controls at post-test (p 
> .05), but significant improvement observed at follow-up (p < .05; 
η2 = .39; b g = 1.95) 
 
Nes, 2012 Psychological: 
 Diabetes-related quality of life (ADDQoL-19) 
 Diabetes-related distress (PAID) 
 
Physical: 
 HbA1c 
 Fasting blood glucose 
 HDL cholesterol, LDL cholesterol and 
triglycerides 
 
Positive lifestyle changes reported by participants with a positive 
trend in HbA1c indicated by descriptive statistics (mean decrease by 
0.49%), suggesting pre-post improvement in glycaemic control 
 
Remaining data available but not analysed by authors as it was a 
feasibility study with a small sample size (n = 11) 
NHS Grampian, 2015 Psychological: 
 Depression and anxiety (HADS) 
 Diabetes-related distress (PAID) 
 
Behavioural: 
 Fitbit weekly step count 
 Physical activity (Scot-PASQ) 
 
Significant pre-post improvements were found in steps walked (p < 
.001; d = .45), physical activity (p = .003; d = .64) anxiety level (p = 
.004; d = .53), depression level (p = .003; d = .53) and diabetes-
related distress (p < .001; d = .56) 
 
A non-significant positive trend was observed in pre-post HbA1c (p 
= .055, d = .24) 
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First Author, Year Outcomes (Measures) 
Main intervention findings 
(reported p and ES, and calculated g) 
Physical: 
 Diabetes control (HbA1c) 
 
 
 
Shayeghian, 2016 Psychological: 
 Coping style strategies (Brief COPE) 
 
Behavioural: 
 Diabetes self-management (SDSCA) 
 
Physical: 
 Glycaemic haemoglobin (HbA1c) 
 
Process: 
 Acceptance of diabetes-related thoughts and 
feelings (AADQ) 
 
Significant pre-post treatment effects relative to controls found for 
HbA1c (p < .001; ηp2 = .25; b g = .26), self-care activities (p < .001; 
ηp2 = .22; b g = .33) and acceptance (p < .001; ηp2 = .44; b g = .59), 
which were maintained at follow-up 
 
Significant moderation effect of coping style found for self-care 
activities (p < .01; ηp2 = .07), but non-significant for acceptance (p 
= .06; ηp2 = .05) and HbA1c (p < .58; ηp2 = .01) 
 
Welch, 2014 Psychological: 
 Diabetes-related distress (DDS) 
 Depression, anxiety and stress (DASS) 
 
Behavioural: 
 Diabetes self-care activities (SDSCA) 
 
Process: 
 Thought Suppression (WBSI) 
 Acceptance of diabetes-related thoughts and 
feelings (AADQ) 
 
Significant pre-post improvement of self-care was found in areas of 
exercise (p < .01; b g = 1.48) and foot care (p < .01; b g = .58); no 
significant treatment effect found in general diet (p = .09), specific 
diet (p = .06), blood glucose testing (p = .38) and smoking status (p 
= .11) 
 
Levels of acceptance and thought suppression significantly 
increased post-treatment (p < .05; b g = 1.69) 
 
Significant pre-post improvement in total diabetes-related distress 
(p < .001; b g = 1.36), emotional burden (p < .001; b g = 1.78), 
regimen-related distress (p < .001; b g = 1.69),  interpersonal distress 
(p < .001; b g = .83), depression (p < .001; b g = .53) and stress (p < 
.001; b g = .64) 
 
No significant treatment effect on physician-related distress (p = 
.04) and anxiety (p = .06) 
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First Author, Year Outcomes (Measures) 
Main intervention findings 
(reported p and ES, and calculated g) 
Whitehead, 2017 Psychological: 
 Anxiety and depression (HADS) 
 Understanding of diabetes management (subscale 
of DCP) 
 
Behavioural: 
 Diabetes self-care activities (SDSCA) 
 
Physical: 
 Glycaemic control (HbA1c) 
 
Process: 
 Acceptance of diabetes-related thoughts and 
feelings (AADQ) 
 
Compared to TAU, no treatment effect was found for HbA1c at six 
months (p = .08) whereas the education only group significantly 
improved HbA1c (p = .01) 
 
No significant pre-post treatment effect relative to TAU were found 
for acceptance of diabetes (p < .95), anxiety (p < .98), depression (p 
< .21), and understanding of diabetes management (p < .53)  
 
A non-significant positive trend (p < .07) was identified for diabetes 
self-care activities, which improved compared to TAU (b g = .30) 
and the education only group (b g = .47) 
 
Type 1 and 2 diabetes   
Moazzezi, 2015 Psychological: 
 Health self-efficacy (SHSES) 
 Perceived stress (PSS) 
Significant treatment effects found compared to controls with a pre-
post increase in health self-efficacy (p < .001; b g = 1.90) and 
positive perceived stress (p < .001; b g = 3.50), and a pre-post 
decrease in total perceived stress (p < .01; b g = .79) and negative 
perceived stress (p < .001; b g = 4.10) 
 
Moghanloo, 2015 Psychological: 
 Depressive symptoms (RCDS) 
 Feelings of guilt (EFGS) 
 Psychological well-being (SWLS) 
Significant treatment effects found compared to controls with a pre-
post increase in psychological well-being (p < .001; b g = 4.33) and 
a pre-post decrease in depressive symptoms (p < .001; b g = 3.76) 
and feelings of guilt (p < .001; b g = 3.54), after controlling for pre-
test scores 
 
Ryan, 2019 Psychological: 
 Resilience (RS) 
 Diabetes-related distress (PAID) 
 Depression, anxiety and stress (DASS) 
 Positive emotions (subscale of PANAS) 
 
Significant pre-post improvement (all p < .01) in resilience (r = .67; 
b g = .55), depression (r = .36; b g = .58), stress (r = .39; b g = .63), 
positive affect (r = .39; b g = .60), psychological flexibility (r = .49; 
b g = .70), valued living (r = .39; b g = .51), step-count (r = .51; b g = 
1.41) and sitting time (r = .52; b g = .55) 
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First Author, Year Outcomes (Measures) 
Main intervention findings 
(reported p and ES, and calculated g) 
Behavioural: 
 Time spent in physical activity per week (AAS) 
 Mean step-count per day (pedometer) 
 Sitting time per day (STQ) 
 
Process: 
 Psychological flexibility (AAQ-II) 
 Mindfulness (MAAS) 
 Valued living (VLQ) 
 
Pre-post improvements in diabetes-related distress (r = .38; b g = 
.43), anxiety (r = .36; b g = .29) and mindfulness (r = .37; b g = .52) 
approached significance (p < .05) due to the use of a more stringent 
significance level (p < .01) 
 
A non-significant positive trend was observed in pre-post time spent 
in physical activity (p > .05, r = .17; b g = .16) 
 
 
Note. ES = effect size; TAU = treatment-as-usual; a Information supplemented using Gregg’s (2004) dissertation; b Calculated effect size with 
small sample bias correction 
Key. AADQ  = Acceptance and Action Diabetes Questionnaire; ADDQoL-19 = Audit of Diabetes Dependence Quality of Life; AAQ-II = 
Acceptance and Action Questionnaire II; AAS = The Active Australia Survey; ATQ = Automatic Thoughts Questionnaire; BDI = Beck Depression 
Inventory; CAMM = Children and Adolescents Mindfulness Measure; CDRS = Connor-Davidson Resilience Scale; DAAS = Diabetes Acceptance 
and Action Scale for Children and Adolescents; DASS = Depression Anxiety Stress Scale; DCP = Diabetes Care Profile; DDS = Diabetes Distress 
Scale; EACS = Emotional Approach Coping Scale; EFGS = Eysenck Feeling of Guilt Scale; GAD-7 = Generalized Anxiety Disorder Scale‑7; 
GHQ-28 = General Health Questionnaire; HADS =  Hospital Anxiety and Depression Scale; IUS =  Intolerance of Uncertainty Scale; MAAS = 
Mindful Attention Awareness Scale; PAID = Problem Areas in Diabetes Scale; PANAS = Positive and Negative Affect Schedule; PSS = Perceived 
Stress Scale; PSWQ = Penn State Worry Questionnaire; RBDI = Revised Beck Depression Inventory; RBQ = Relationships Beliefs Questionnaire; 
RCDS = Reynolds’ Child Depression Scale; RS = Resilience Scale; Scot-PASQ = Scottish Physical Activity Screening Question; SDSCA = 
Summary of Diabetes Self‐Care Activities; SF-36 = Short Form Health Survey; SES = Self-Efficacy Scale; SHSES = Special Health Self-Efficacy 
Scale; STQ = Sitting Time Questionnaire; SWLS = Satisfaction with Life Scale; VLQ = Valued Living Questionnaire; WBSI = White Bear 
Suppression Inventory 
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Study results 
The main findings of the studies are presented in Table 3 with reported effect 
sizes and calculated effect sizes when means and standard deviations were reported. 
Three studies investigating outcomes of people with either diagnosis were considered 
independently as the available data in the full-text papers did not facilitate calculation 
of statistics separated by diagnosis. 
T1D-specific outcomes 
Only one study exclusively investigated the impact of ACT on people with 
T1D, focusing on psychological, physical and process outcomes only. Lehikoinen and 
Honkanen (2018) found that their 10-week ACT-based group programme did not 
significantly improve adolescents’ depression, anxiety and HbA1c post-treatment 
compared to those assigned to treatment-as-usual, despite finding a significant post-
intervention improvement in participants’ diabetes-specific psychological flexibility 
and ability to manage diabetes (small to medium effect size). 
T2D-specific outcomes 
Psychological outcomes. Overall, mixed results were found for some of the 
psychological outcomes. Depression was investigated by five studies, out of which 
two quasi-experimental studies found significant pre-post large effect sizes 
(Ahmadsaraei et al., 2017; Hor et al., 2014), two single-group design studies found 
significant pre-post medium effect sizes (NHS Grampian, 2015; Welch, 2004), and 
one RCT found no pre-post significant difference (Whitehead et al., 2017). These 
differences in outcomes could be related to differences in study design. 
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Two studies identified significant pre-post improvements with medium effect 
sizes on anxiety level (NHS Grampian, 2015; Ghasemlou & 
Nezhadmohamadnameghi, 2018), whilst two other studies found no pre-post 
significant differences (Welch, 2014; Whitehead et al., 2017). Fayazbakhsh and 
Mansouri (2019) investigated more specific anxiety symptoms, finding significant 
pre-post improvements with large effect sizes for general anxiety disorder symptoms, 
worry and intolerance of uncertainty. 
Diabetes-related stress was investigated by three studies, although only two 
analysed their findings which showed pre-post improvements with medium to large 
effect sizes (NHS Grampian, 2015; Welch, 2014). Welch (2014) also identified 
significant pre-post improvement in stress levels with a medium effect size. Quality of 
life was investigated by two studies, but only one study analysed the findings, 
identifying a significant pre-post improvement in quality of life with a large effect 
size (Ghasemlou & Nezhadmohamadnameghi, 2018). No significant pre-post 
improvements in understanding of diabetes management were found by two studies 
(Gregg et al., 2007; Whitehead et al., 2017). 
Psychological outcomes were largely heterogeneous with some outcomes only 
being investigated by one study. Khashouei and colleagues (2016) found significant 
post-treatment improvements with a medium to large effect size in self-efficacy and 
perceived stress, which were maintained at follow-up. They also examined 
participants’ resilience, only finding significant improvement at follow-up with a 
large effect size. Significant post-treatment improvements with a large effect size 
were found for marital satisfaction, dysfunctional communicative attitude and general 
mental health (Amirfakhraei et al., 2016; Kaboudi et al., 2017). Shayeghian and 
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colleagues (2016) investigated coping style as a potential psychological moderator, 
identifying that it was only significant for self-care activities accounting for 7% of the 
variance. 
Behavioural outcomes. Five studies investigated the behavioural outcomes of 
ACT-based interventions in people with T2D. Two RCTs found significant 
improvements in diabetes self-management and self-care of small to medium effect 
size at follow-up (Gregg et al., 2007; Shayeghian et al., 2016) and one RCT found a 
non-significant pre-post positive trend in comparison to treatment-as-usual and an 
active education only control group (Whitehead et al., 2017). In line with this, Nes 
and colleagues (2012) noted positive lifestyle changes reported by participants 
following their online intervention, although they did not formally analyse their 
results due to their small sample size. Examining self-care more closely, Welch 
(2004) found significant post-treatment improvement with a medium to large effect 
size in areas of self-care pertaining to exercise and foot care, but no significant 
improvements in general diet, specific diet, blood glucose testing and smoking status 
were identified. Only one study did not use self-report questionnaires to measure 
behavioural outcomes; NHS Grampian (2015) investigated steps walked by 
participants and time spent in physical activity following their guided self-help 
programme, identifying significant improvements of small to medium effect size. 
Physical outcomes. Of the five studies that investigated glycaemic control, 
one RCT found a significant improvement in HbA1c of small effect size at follow-up 
(Shayeghian et al., 2016).  The remaining four studies identified non-significant 
positive trends in HbA1c at follow-up (Gregg et al., 2007; Nes et al., 2012; NHS 
Grampian, 2015; Whitehead et al., 2017). Thus, it may be that ACT interventions’ 
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impact in reducing HbA1c levels may be too negligible to be considered statistically or 
clinically significant. However, Gregg and colleagues (2007) reported a significant 
improvement in the number of participants within target diabetes control status 
following their group workshop. Nes and colleagues (2012) identified a post-
treatment positive trend in fasting blood glucose and cholesterol but did not formally 
analyse this due to their small sample size. 
Process outcomes. Diabetes-specific acceptance was measured by four 
studies using the same measure (AADQ) with varying results and effect sizes. One 
RCT found no pre-post significant improvement in diabetes acceptance (Whitehead et 
al., 2017), whereas two other trials found significant improvements at follow-up with 
a less than small effect size (Gregg et al., 2007) or medium effect size (Shayeghian et 
al., 2016). A large pre-post effect size was found by a single-group design study 
(Welch, 2014). A significant post-treatment reduction in experiential avoidance with a 
large effect size was noted by Fayazbakhsh and Mansouri (2019). Welch (2014) 
found significant pre-post improvement in thought suppression. However, Gregg 
(2004) also investigated a range of other process variables (e.g. thought suppression 
and emotional avoidance) which did not change significantly post-intervention 
compared to an active control condition. 
Outcomes of studies combining T1D and T2D 
Psychological outcomes. The psychological outcomes investigated by studies 
combining people with T1D and T2D were largely heterogeneous, with only 
depression as a common measure in two studies which identified significant post-
treatment improvements of medium to large effect size (Moghanloo et al., 2015; Ryan 
et al., 2019). Ryan and colleagues (2019) found a significant pre-post improvement in 
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adults’ resilience, depression, stress and positive affect with medium effect sizes, but 
no significant difference in diabetes-related distress and anxiety. Moghanloo and 
colleagues (2015) also identified significant post-treatment improvements of feelings 
of guilt and psychological well-being in children with large effect sizes. Moazzezi and 
colleagues (2015), who appeared to be utilising the same intervention as Moghanloo 
(2015), found a large effect size pre-post improvement in the health self-efficacy and 
perceived stress of children. 
Behavioural outcomes. Only one study combining T1D and T2D examined 
behavioural outcomes. Ryan and colleagues (2019) identified a non-significant post-
treatment positive trend in time spent in physical activity, a significant increase in 
step-count (large effect size) and a significant reduction in sitting time (medium effect 
size).  
Process outcomes. Only one study combining T1D and T2D investigated 
process outcomes. Ryan and colleagues (2019) found that psychological flexibility 
and valued living significantly improved following their intervention (medium effect 
size) but there were no significant changes in mindfulness. 
Physical outcomes. None of the studies combining T1D and T2D investigated 
physical outcomes. 
Discussion 
In light of the increasing clinical interest in the use of ACT interventions to 
support the diabetes population, the present review aimed to systematically describe 
the characteristics of existing ACT interventions for people with diabetes and to 
investigate the extent to which ACT improves diabetes-related outcomes.  
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Summary of evidence 
Reviewing the characteristics of ACT interventions for diabetes revealed that 
they have been investigated in a variety of formats, although group interventions were 
considerably more prevalent. Although the interventions varied in content and length, 
the relatively good completion rates demonstrate the acceptability and feasibility of 
ACT in this population. Key features of ACT, including the core components of 
psychological flexibility, appeared to be conveyed through the use of metaphors, 
exercises and discussions. However, a general lack of clarity regarding the content of 
treatment manual, therapist training and treatment fidelity was identified in the 
majority of reviewed studies. 
Most of the reviewed studies targeted adults with T2D with ACT-based group 
interventions. Examining these studies revealed that the interventions were associated 
with small to large improvements in a range of behavioural and psychological 
outcomes such as diabetes self-care, physical activity, diabetes-related distress, self-
efficacy, worry and quality of life. Mixed findings were found in relation to the 
impact of ACT on depression, anxiety and resilience. Whilst glycaemic control 
appeared to improve following ACT, only one study reported a significant reduction 
in HbA1c levels. Inconsistent findings became apparent when reviewing changes in 
ACT-related processes, particularly in relation to diabetes acceptance and thought 
suppression. 
Only one study investigated the impact of ACT in supporting the T1D 
population, identifying a small to medium significant improvement in diabetes 
acceptance following a group-based intervention for adolescents, but no significant 
changes in other psychological outcomes. Two studies that combined T1D and T2D 
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populations targeted children, demonstrating improvements in a range of 
psychological outcomes, such as health self-efficacy, perceived stress, well-being, 
depressive symptoms and feelings of guilt. Another study investigated adults with 
either diagnosis, although the majority had T2D, and detected small to large 
improvements in a range of psychological, behavioural and ACT-based process 
outcomes, similar to the T2D study results, although changes in diabetes-related 
distress, mindfulness and anxiety were not significant. 
Strengths and limitations of the review 
The present review had several strengths. Given the paucity of the literature in 
this topic area, the research questions and search strategy were deliberately broad to 
enable a comprehensive review of the existing ACT for diabetes literature, although a 
drawback was the exclusion of non-English studies. Searching the grey literature 
minimised the risk of publication bias and increased the likelihood that the review is 
representative of the existing literature. Further, the inclusion of the grey literature 
enabled the identification of the only T1D study included in the review (Lehikoinen & 
Honkanen, 2018) as well as a higher quality study (NHS Grampian, 2015). It also 
broadened the number and type of diabetes-related outcomes captured by the review. 
However, this methodology may have introduced lower quality studies as the studies 
may have not been peer-reviewed, in addition to introducing a subjective element, 
which deviates from the systematic nature of the review. Relevant qualitative studies 
were identified but excluded as analysing these was beyond the scope of the review. 
However, a future systematic review exploring qualitative research studies of ACT 
among people with diabetes is recommended to gain a better understanding of 
individual experiences of ACT interventions targeting diabetes-related outcomes. 
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The use of a second reviewer minimised the risk of researcher bias and 
methodological errors. Furthermore, using small sample bias-corrected estimates of 
treatment effects enabled a fairer comparison of individual findings. However, the 
heterogeneous nature of the studies, combined with the limited literature, made it 
difficult to draw firm conclusions about which outcome measures ACT has a reliably 
beneficial impact on, for whom specifically and in what circumstances. For example, 
the inclusion of one study into the impact of ACT on adolescents with T1D precludes 
the generalisation of the findings to the wider T1D population. As a large proportion 
of the studies were conducted with people with T2D in Iran, it remains unclear how 
applicable these findings might be to other T2D populations.  
A drawback of the review was that a meta-analysis was not conducted as it 
could have provided a more systematic framework for synthesising study findings, 
which would have led to greater confidence in the conclusions drawn. Although the 
studies used different standardised questionnaires to measure similar diabetes-related 
outcomes, a meta-analysis could have been conducted to examine more commonly 
investigated outcomes such as depression, anxiety, diabetes-related distress, HbA1c 
and diabetes self-management in the type 2 diabetes population, by employing a 
random-effects method to allow for a more conservative approach for reporting effect 
sizes (Borenstein et al., 2010). The calculated effect sizes and confidence intervals 
could have helped to inform future trials into the use of ACT with people with 
diabetes, in terms of the number of participants necessary to achieve sufficient 
statistical power. Given the considerable heterogeneity of the studies, the I2 statistic 
could have been used to assess heterogeneity quantitatively (Higgins et al., 2019). As 
some of the included studies were assessed as having a high risk of bias, sensitivity 
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analyses could have been conducted to identify and acknowledge the influence of 
these biases on the findings (Higgins et al., 2019). 
Strengths and limitations of the included studies 
Whilst the ACT for diabetes literature has advanced, the review has 
highlighted the lack of high-quality studies in the field in addition to some 
inconsistencies between findings. Following the quality assessment, no notable 
differences in the results were observed by overall quality rating, although this was 
not objectively measured. However, as the majority of the studies obtained an overall 
quality rating of ‘weak’, the results should be interpreted within the context of the 
studies’ limitations. The quality assessment identified strengths in the studies’ 
research design, control of confounders and data collection methods. However, 
shortcomings in these areas were also observed. Only a few studies included an active 
control group, increasing the possibility that some discrepancies between findings 
may be linked to the robustness of the research designs employed. For example, 
significant improvements in thought suppression were found in a single-group design 
study but not in an RCT (Gregg et al., 2007; Welch, 2014). The use of interventions 
incorporating additional components without active control conditions and the 
minimal amount of follow-up data make it difficult to discern the precise impact of 
ACT in the long-term. The inclusion of studies that combined T1D and T2D samples 
enabled the comparison between separated and combined diabetes populations in the 
review, but it introduced ambiguity with regards to whether improvements were 
associated more with one population over the other. 
The use of generic outcomes measures over validated diabetes-specific ones in 
some studies may have also resulted in a reduced sensitivity to detecting change. 
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Power calculations were not reported in most studies, and with the sample sizes 
varying from 11 to 157, it is unclear whether studies had enough statistical power to 
detect differences in outcomes. Moreover, it might be more clinically meaningful to 
measure whether participants reach their target glycaemic control, as measured by 
Gregg and colleagues (2007) in their RCT. Other study weaknesses included the 
overall lack of information on blinding procedures, number of participant withdrawals 
and dropouts, treatment adherence and therapist training as well as the use of 
convenience sampling. These increase the risk of reporting bias and selection bias. 
Whilst appropriate ACT-based exercises were named in some intervention 
descriptions, it remains unclear how appropriately these exercises were explained and 
interwoven into the interventions. 
Discrepancies in results may also be due to other potential confounding 
factors. For example, the impact of ACT on diabetes acceptance was found to vary 
from no effect to a significantly large positive effect (Gregg et al., 2007; Shayeghian 
et al., 2016; Welch, 2014; Whitehead et al., 2017). Examining the methodologies 
employed by these studies revealed a substantial difference in the participants’ 
average diabetes duration (from three months to 10 years), which may suggest that 
participants who had been diagnosed more recently experienced a greater increase in 
their diabetes acceptance after ACT compared to those who have had diabetes for 
many years. Overall, these study limitations and the results of the quality assessment 
indicate that caution is needed when drawing conclusions about the extent to which 
ACT is effective in improving diabetes-related outcomes. 
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Findings in context of existing evidence and theory 
To the author’s knowledge, this is the first review to focus solely on the 
impact of ACT on the diabetes population. Preliminary evidence to support the use of 
ACT in the diabetes field was highlighted by two previous systematic reviews which 
included six studies examined in the review (Graham et al., 2016; Massey et al., 
2019). In line with Massey and colleagues’ findings (2019), our review suggests that 
ACT has a beneficial impact on diabetes self-management and may improve various 
aspects of psychological health. The significant improvement in diabetes-related 
distress for people with T2D was in keeping with findings of a recent meta-analysis 
on the impact of diabetes-tailored psychological interventions (Schmidt et al., 2018). 
The impact of ACT on psychological factors such as depression and anxiety appears 
promising despite a few inconsistent results, as these variations in findings have also 
been found in systematic reviews of other psychological interventions (Pascoe et al., 
2017; Steed et al., 2003). ACT appeared to have an overall positive effect on 
psychological health for people with T1D and T2D, although firm conclusions cannot 
be drawn due to the paucity of the literature. 
The review challenges previous literature stating that ACT may be effective in 
improving glycaemic control, although the poor quality of studies questions the 
validity of this finding (Massey et al., 2019). The lack of treatment effect on HbA1c 
levels has also been demonstrated in people with T1D and T2D following broader 
psychological interventions (Winkley et al., 2020a; Winkley et al., 2020b). An 
explanation might be that ACT may have a comparable minimal impact on glycaemic 
control. Additionally, HbA1c levels may have been measured too early to detect 
change, or changes may be too negligible to detect. However, a recent meta-analysis 
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found that psychological interventions that were tailored specifically to diabetes 
significantly reduced HbA1c levels in adults with diabetes (Schmidt et al., 2018). The 
differences in these findings may be due to factors such as the difficulty of targeting 
multiple outcome measures simultaneously and an insufficient emphasis on 
addressing diabetes-specific issues to enable improvements in glycaemic control 
(Chew et al., 2018; Schmidt et al., 2018). 
ACT’s focus on acceptance and on living a meaningful life is likely to be 
attractive to clinicians when considering how best to support people with long-term 
health conditions such as diabetes (Graham et al., 2016). However, it was difficult to 
ascertain which components of psychological flexibility reliably change following 
ACT and how they contribute towards subsequent changes in diabetes-related 
outcomes, particularly as people’s understanding of diabetes did not seem to change. 
Further exploration of the underlying mechanisms of ACT in this context is 
necessary. 
Practice and research implications 
The growing interest in ACT in the diabetes field is reflected by the high 
number of studies published in the past five years. The research indicates that this is a 
promising area for clinical practice given the range of intervention modalities, which 
showed significant improvements or at least changes in a positive direction in the 
aforementioned psychological and behavioural outcomes. Group-based ACT 
interventions for adults with T2D were investigated by the majority of studies, 
suggesting that ACT is not only feasible to implement, but is also relevant and 
applicable to T2D, though an outstanding question is whether the benefits of ACT are 
clinically significant. Promising results were observed in the studies that included 
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people with T1D; however, more research is required to ascertain the specific impact 
of ACT in T1D. Emerging high-quality studies into T1D (e.g. Amsberg et al., 2018) 
were not included in the review as the data is not yet available. As the literature 
expands, a meta-analysis employing a random-effects method is recommended as a 
more objective way of synthesising the evidence, including calculation of the I2 
statistic to measure heterogeneity and conducting sensitivity analyses to examine the 
impact of biases on the findings. 
The impact of the poor research quality in increasing the risk of bias in the 
literature, combined with the heterogeneous nature of the studies in terms of their 
methodology, outcomes of interest and target population, made it difficult to generate 
firm conclusions about the effectiveness of ACT. The quality assessment highlighted 
areas for future studies to improve. Future research should use high-quality research 
designs such as RCTs with active control conditions and longitudinal follow-ups to 
elucidate the precise impact of ACT over time. Furthermore, larger sample sizes 
based on power calculations and rigorous participant selection methods are advised to 
minimise sampling bias and error. There is also a need for consensus on the main 
outcomes of interest and the use of diabetes-specific measures over general measures 
to enable valid and reliable measurements of change over time and to enable 
comparisons between different study findings. 
Finally, whilst it is acknowledged that journal word count limits must be 
abided by, to minimise reporting bias, there is a need for publications in this research 
area to provide key information such as details of blinding procedures and numbers of 
participant withdrawals and dropouts. Information about treatment adherence and 
therapist training should also be reported to examine the validity of ACT 
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interventions. More transparency about the interventions through publishing treatment 
manuals will enable future research to investigate the underlying mechanisms of ACT 
by examining process measures such as the different components of psychological 
flexibility. Future research should also explore individual differences such as the role 
of diabetes duration as it may have clinical implications for targeting people with 
diabetes at an earlier stage. 
Overall, the systematic review has provided evidence that ACT interventions 
may have a beneficial impact on the diabetes self-management and diabetes-related 
psychological outcomes of people with T2D, but their impact on physical health 
remains inconclusive. More research is necessary to evaluate the impact of ACT on 
the diabetes-related outcomes of people with T1D. ACT may have the potential to 
address a future direction for diabetes care delivery, although high-quality research is 
needed to enable valid and reliable conclusions to be drawn about its precise impact. 
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III. Comparison of two online ACT-based interventions for adults with insulin-
treated diabetes: a pilot RCT 
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Abstract 
The aims of the pilot study were: to investigate the impact of two online four-week, 
self-help interventions based on Acceptance and Commitment Therapy components (a 
values-plus-goals intervention [VGI] and a mindfulness-based intervention [MBI]) on 
well-being, diabetes self-management and glycaemic control of adults with insulin-
treated diabetes; and to determine whether improvements in these outcomes were 
associated with changes in diabetes acceptance and valued living. A randomised 
controlled mixed design was employed. The final sample consisted of 29 insulin-treated 
adults with type 1 or 2 diabetes in the VGI (n = 17) and the MBI (n = 12) conditions. 
Participants completed the Well-being Questionnaire, Diabetes Self-Management 
Questionnaire, Diabetes Acceptance Scale, and Valued Living Questionnaire pre- and 
post-intervention, and at a one-month follow-up. HbA1c levels were collected at 
baseline and follow-up. Participants in the MBI condition experienced non-significant 
improvements in their well-being and diabetes acceptance over time; these changes 
were significantly associated post-intervention, but not at follow-up. Participants in the 
VGI condition experienced a non-significant pre-post improvement in their diabetes 
self-management, which was maintained at follow-up. Subscale analyses revealed that 
only the dietary control component of diabetes self-management significantly improved 
over time. Improvements in valued living did not reach statistical significance and no 
significant associations were found between changes in valued living and diabetes self-
management over time. Follow-up HbA1c values were obtained for five participants, of 
whom four experienced clinically meaningful reductions. Study limitations included 
low statistical power, methodological weaknesses, and lack of control over potential 
confounding factors. The results, combined with participant feedback, suggest that brief 
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online interventions may have potential in expanding access to psychological input for 
people with diabetes. However, further research is recommended to gain insight into 
their clinical benefit using more robust studies with a larger sample size and longer 
follow-up.  
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Introduction 
The challenges of diabetes 
Diabetes mellitus is a chronic physical health condition affecting 
approximately 3.8 million people in the UK (Diabetes UK, 2019). Type 1 diabetes 
(T1D) and type 2 diabetes (T2D) distinguish between those who cannot produce 
insulin and those who no longer respond to insulin, respectively. Typically, insulin 
therapy is used to control blood glucose levels in T1D, whilst oral antidiabetic 
medication is used in T2D; however, insulin therapy is recommended in more poorly 
managed cases of T2D as well (DeWitt & Hirsch, 2003). As described on p. 20-21, 
diabetes poses a significant health challenge through increasing the risk of developing 
acute and chronic complications. Daily self-management is required to reduce this 
risk, which can be complex and difficult (George et al., 2014).  
The “Too Often Missing” report highlighted that people with diabetes also 
face significant psychosocial challenges that can act as barriers to maintaining good 
diabetes self-care (Askew & Solomons, 2019). As discussed on p. 22-24, people with 
diabetes can experience disruptions to daily life alongside a variety of psychological 
difficulties ranging from low mood to diabetes-specific distress (Barnard et al., 2012; 
Nicolucci et al., 2013; Rane et al., 2011). Some individuals may use unhelpful coping 
strategies which prevent them from achieving optimal blood glucose levels (Sturt et 
al., 2015). These difficulties have been linked to a greater risk of complications and 
mortality, increasing the economic burden on healthcare services by up to double the 
expected cost (Diabetes UK, 2019; Lustman & Clouse, 2005; Eiser et al., 2001; 
Moussavi et al., 2007). 
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Psychosocial interventions for people with diabetes 
With the growing incidence of diabetes, the importance of improving the 
outcomes for people with diabetes has been stressed as a national priority and there is 
an increasing recognition of the need to meet the psychological needs of people with 
diabetes (NHS England, 2018). A range of psychosocial interventions have been used 
to target the well-being and health outcomes of individuals with diabetes, including 
counselling, psychodynamic therapy and CBT; however, systematic reviews and 
meta-analyses in the field have found that there is mixed evidence regarding their 
effectiveness (Chew et al., 2017; Pascoe et al., 2017; Steed et al., 2003; Winkley et 
al., 2020a; Winkley et al., 2020b). These approaches often target negative diabetes-
related thoughts, emotions and behaviour, as well as unhelpful coping strategies such 
as avoidance (e.g. not monitoring blood glucose levels) which has been associated 
with poor diabetes self-management (Weijman et al., 2005). Approaches that focus on 
challenging thoughts such as CBT may be limited in their impact, as individuals’ 
thoughts related to chronic health conditions are often linked to the possibility of 
realistic consequences (Hofmann et al., 2010).  
Acceptance and Commitment Therapy (ACT; Hayes et al., 1999) is an 
alternative therapeutic approach falling within the “third wave” CBT interventions, 
which has shown promise in the field of long-term health conditions (Graham et al., 
2016). ACT moves away from attempts to alter internal experiences and promotes 
psychological flexibility in relation to individuals’ relationship with their thoughts, 
feelings and behaviour.  Psychological flexibility consists of six interrelated processes 
captured by the “Hexaflex” (see Figure 1, p. 27). These processes lend themselves to 
improving the well-being and health of people with diabetes by enabling individuals 
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to be mindful of and accept their internal experiences as they are, and to strive to live 
a meaningful life based on their personal values (Hadlandsmyth et al., 2013). 
The evidence base for ACT in diabetes 
Given the relative ease of applying ACT concepts to difficulties linked to 
chronic health conditions, there is a growing interest in ACT internationally as it is 
seen as a promising approach for improving diabetes-related outcomes, with an 
emerging evidence base. One of the first published studies in this area was conducted 
by Gregg and colleagues in 2007. They randomly assigned 81 patients with T2D to 
either an education-alone control group focused on diabetes self-management or a 
combined education and ACT workshop, which included learning and applying 
acceptance and mindfulness skills to diabetes-related thoughts based on an “ACT and 
diabetes self-management” manual which they later published. Their findings 
suggested that the participants who took part in the ACT workshop experienced 
greater improvements in their coping styles, diabetes self-management and glycaemic 
control compared to the education-only group. 
Other trials of ACT interventions (see Table 3) have since been published 
which have shown improvements in a range of diabetes-related outcomes such as self-
care, physical activity, depression, distress, worry, quality of life and stress, although 
some findings were inconsistent (Ahmadsaraei et al., 2017; Fayazbakhsh & Mansouri, 
2019; Ghasemlou & NezhadmohamadNameghi, 2018; Khashouei et al., 2016; 
Moghanloo et al., 2015). Shayeghian et al. (2016) conducted a study based on 
Gregg’s manual (2007), randomly assigning 100 adults with T2D to either a group-
based 10-session ACT intervention combined with education or an education-alone 
group focused on diabetes self-management. They found that participants in the ACT 
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group had more effective coping strategies, higher acceptance, better diabetes self-
care, and optimum HbA1C levels in the target range (a measure of average blood 
glucose level over three months), which remained stable at a 3-month follow-up. 
Similarly, Lehikoinen and Honkanen (2018) found that adolescents with T1D who 
took part in an ACT group, experienced significantly greater psychological flexibility 
than those who received treatment-as-usual. Thus, ACT interventions have been 
shown to be promising in diabetes populations. 
The current challenge 
Whilst ACT may be theoretically and practically suited to address the 
psychological needs of the diabetes population, it is difficult to deliver in the current 
NHS. There is a national lack of psychology funding in diabetes services with only 
15% of services having access to diabetes-specific psychological support (Diabetes 
UK, 2008). The “Too Often Missing” report highlighted that 75% of people with 
diabetes requiring specialist psychological support felt that they could not access the 
support they needed (Askew & Solomons, 2019). Thus, there is a need for financially 
feasible and accessible interventions to support the well-being of patients with 
diabetes. 
Web-based interventions 
One way this has been addressed is through the use of web-based mental 
health interventions, which have increasingly become popular over the past three 
decades (Barak & Grohol, 2011). ACT has been delivered online successfully in the 
diabetes population through the use of smartphones and web-based modules. For 
example, as part of a quality improvement project to deliver an unmet need in the 
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NHS Grampian Trust (2015), a trial of a brief guided self-help ACT programme 
“ACT Now!” was conducted with 27 adults with T2D who had difficulty managing 
their condition (indicated by their glycaemic control, which was in the poorest 40% of 
the Grampian T2D population). This involved 5-8 face-to-face meetings and web-
based modules, focusing on diabetes self-management, health-related behaviours, 
anxiety, depression and diet. Overall, their qualitative interviews showed that the 
programme was acceptable, feasible to deliver and helpful. The participants 
experienced significant improvements in their ability to walk greater distances and 
reduced levels of anxiety, depression and diabetes-related distress. Similarly, Nes and 
colleagues (2012) conducted a feasibility pilot of a web-based 12-week ACT 
intervention via smartphone aimed at adults with T2D, which included mindfulness 
and identifying individuals’ values, with the aim of supporting their self-management. 
They found that it was feasible and resulted in positive lifestyle changes. Nes and 
colleagues (2018) examined treatment fidelity and concluded that the different 
processes within ACT can be delivered on the web in a written format. Therefore, 
web-based ACT interventions may be an effective and financially feasible way of 
addressing the psychological needs of people with diabetes. 
Modular interventions 
ACT is also a transdiagnostic approach that can be delivered in individual 
modules by targeting the specific processes that encompass psychological flexibility 
(Hayes et al., 1999). Thus, another solution could be the development of interventions 
that target specific ACT components. For example, Villatte and colleagues (2016) 
investigated two ACT component-based interventions (acceptance and values) in a 
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transdiagnostic adult sample, recommending that ACT components should be 
implemented as modular psychological interventions.  
Karekla and colleagues (2018) proposed links between ACT and the Common 
Sense Model (CSM; Leventhal et al., 1992), a widely-used health and illness self-
regulation model that outlines how individuals emotionally and behaviourally adapt to 
their health condition (see Figure 3). The CSM proposes that individuals with a health 
condition or illness all experience emotions and have beliefs related to the cause, 
consequences, identity (meaning assigned to symptoms), curability/controllability and 
timeline of the illness. This leads individuals to adopt coping strategies which can be 
adaptive (e.g. acceptance, problem-focused coping, seeking social support) or 
maladaptive (e.g. avoidance, substance misuse), which have an impact on their 
emotional state and health outcomes (e.g. physical functioning, well-being, illness 
state). The CSM posits that through a feedback loop, individuals undergo a dynamic 
and continuous process of appraisal and adjustment of their coping strategies by 
comparing their experience against their desired outcome (Leventhal et al., 1992). 
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Karekla and colleagues (2018) proposed that the components of the ACT 
hexaflex can be used to target and facilitate the dynamic process of adaptation to 
illness and behaviour change posited in the CSM. The CSM theorises that individuals 
have habitual mechanisms that are involved in illness self-regulation. When 
individuals perceive illness representations as the only valid truth (also known as 
cognitive fusion in ACT), this can lead to rigid and problematic ways of coping, such 
as emotional avoidance–a maladaptive form of emotion-focused coping. Through 
applying the mindfulness, acceptance and cognitive defusion components of the ACT 
hexaflex, individuals can learn a different way of coping through disengaging from 
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The Common Sense Model of Health and Illness Self-regulation 
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these habitual mechanisms, and recognising and facing experiences as they are, giving 
them more choice for their subsequent behaviour (Karekla et al., 2018). 
The CSM also emphasises the importance of having specific goals and actions 
to support self-regulation and how these are shaped within the context of individuals’ 
self-system, that is, in according with their personal attitudes, identities and goals 
(Leventhal et al., 1992). The self-as-context, values and committed action components 
of the ACT hexaflex have been proposed to complement the CSM in this respect by 
aiming to clarify individuals’ values and find meaning as to why behaviour change is 
personally important to them, which could facilitate better adaptation to illness by 
encouraging value-based actions (Karekla et al., 2018). 
Mapping ACT components on the CSM can increase our theoretical 
understanding of how different components of ACT can be helpfully applied to the 
difficulties experienced by people with diabetes. Based on Karekla and colleagues’ 
suggested intervention strategies combining the two models, it is proposed that an 
intervention based on the ACT components of values and committed action may 
promote more active, problem-focused coping styles through incorporating awareness 
of personal values, setting goals and encouraging committed action, as value-
congruent behaviours could help to motivate individuals to act in line with their self-
management plan, a vital part of adaptation to diabetes (Chew et al., 2018; Oftedal et 
al., 2010). An intervention based on the mindfulness and acceptance components of 
ACT may promote positive emotion-focused coping through helping individuals to 
mindfully acknowledge and live alongside difficult internal experiences, including 
any negative cognitive and emotional illness representations they may have (Hayes et 
al., 1999). Therefore, learning these ACT skills may result in improvements in coping 
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strategies and diabetes-related outcomes. Further, having a better understanding of the 
effectiveness of different components of ACT would allow services to provide a brief 
and more financially-feasible targeted intervention that is tailored to individuals with 
diabetes. However, no research examining different components of ACT with people 
with diabetes has been published to date.  
Aims 
The present pilot study aimed to extend previous research on using ACT to 
support the diabetes population by taking a modular approach and examining the 
impact of two four-week online ACT component-based interventions (a values-plus-
goals intervention [VGI] and a mindfulness-based intervention [MBI]) in improving 
the well-being, diabetes self-management and glycaemic control of a sample of 
insulin-treated adults with T1D or T2D, who had suboptimal glycaemic control 
(HbA1c ≥64mmol/mol). Individuals with either T1D or insulin-treated T2D were 
targeted as they have similar treatment demands and impact, enabling the intervention 
to be accessible to anyone on insulin therapy. The study aimed to determine whether 
these interventions resulted in improvements in these diabetes-related outcomes post-
intervention and at a one-month follow-up, and whether improvements were 
associated with changes in diabetes acceptance and valued living. The hypotheses 
were as follows: 
(1) In the MBI group, self-reported well-being will be significantly greater at post-
intervention and follow-up than at pre-intervention. In the VGI group, self-
reported diabetes self-management activities will have significantly improved at 
post-intervention and follow-up compared to pre-intervention. Glycaemic control 
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will have significantly improved at follow-up compared to pre-intervention in the 
VGI group. 
(2) The MBI will be associated with increased diabetes acceptance at post-
intervention and follow-up, whilst the VGI will be associated with increased 
valued living at post-intervention and follow-up. 
(3) In the MBI group, improvement in self-reported well-being at post-intervention 
and follow-up will be associated with an increase in diabetes acceptance. In the 
VGI group, improvement in self-reported diabetes self-management activities and 
glycaemic control at post-intervention and follow-up will be associated with an 
increase in valued living. 
Method 
Research approval 
Ethical approval was obtained from the London – Surrey Research Ethics 
Committee (REC reference: 19/LO/1096; Appendix B), the Health Research 
Authority (Appendix C) and the Research Ethics Committee at Royal Holloway, 
University of London (Appendix D). Local research approval was granted by the 
Research and Development Department at Ashford and St Peter’s Hospitals (ASPH) 
NHS Foundation Trust (Appendix E).  
Participants 
Power analysis 
Given that no previous study to date has compared ACT component-based 
interventions in the diabetes field, the effect sizes of the interventions were unknown. 
An apriori analysis on G*Power, a statistical analysis software, was completed to 
84 
 
calculate the number of participants required to test the primary research hypothesis, 
considering diabetes self-management as the primary outcome of the present study 
(Erdfelder et al., 1996). An estimated effect size of d = .65 was used based on 
previous studies investigating the impact of ACT interventions in improving diabetes 
self-management (Gregg et al., 2007; Shayeghian et al., 2016). To conduct repeated 
measures analysis of variance with three measurements and with an effect size of d = 
.65, α = .05 and power = .80, a sample size of 20 per group was required to detect 
significant changes related to the study hypotheses. Based on previous diabetes 
research, it was anticipated that the response rate would be approximately 58% 
(between 32-83%; Ramadas et al., 2011) and that the attrition rate would be 10% (Pal 
et al., 2013). Thus, the target sample size was a minimum of 20 participants in each 
group, with the understanding that 80 participants could be required to achieve this.  
Sample description 
Between October 2019 and April 2020, a total of 63 people with diabetes 
treated with insulin were recruited. Seven participants (11.1%) dropped out before 
completing the sociodemographic questionnaire and pre-intervention measures, 
resulting in a sample of 56 participants who were randomly allocated to take part in 
either the MBI or the VGI. The final sample size, based on those who completed pre- 
and post-intervention outcome measures, was 29 (MBI: n = 12; VGI: n = 17). 
Of the 12 participants in the MBI condition, all reported belonging to White 
ethnic groups, seven were men and nine had a diagnosis of T1D. The sample had a 
mean age of 51.3 years (SD = 12.5), mean BMI of 27.1 (SD = 4.03), mean duration of 
diabetes of 22.3 years (SD = 13.1) and mean insulin treatment duration of 18.1 years 
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(SD = 15.5). Approximately half the sample reported having either long-term diabetes 
complications (n = 1), other comorbid health conditions (n = 2) or both (n = 4). 
Of the 17 participants in the VGI condition, 16 reported belonging to White 
ethnic groups, nine were men and 13 had a diagnosis of T1D. The sample had a mean 
age of 45.7 years (SD = 18.1), mean BMI of 29.5 (SD = 6.38), mean duration of 
diabetes of 21.6 years (SD = 16.5) and mean insulin treatment duration of 18.9 years 
(SD = 17.5). Over two-thirds of the sample reported having either long-term diabetes 
complications (n = 3), other comorbid health conditions (n = 6) or both (n = 3). 
Further sociodemographic characteristics of the samples are presented in Appendix F, 
Table F1. 
Recruitment 
The majority of potential participants were recruited through diabetes clinics 
at ASPH NHS Foundation Trust (n = 259) during an 18-week period between October 
2019 and March 2020. Flyers and posters (Appendix G) were displayed in the 
diabetes clinic waiting area and consultation rooms, encouraging interested 
participants to check their eligibility to take part with the diabetes team and to obtain 
a paper copy of the participant information sheet (PIS; Appendix H) and consent form 
(Appendix I). Clinicians and nurses were asked to raise awareness of the study to 
eligible patients at the end of their consultations, where possible, and to share the 
contact details of the researcher by providing a PIS. Eligible patients attending the 
diabetes clinics were also approached by the researcher to raise awareness of the 
study with their verbal consent. In the absence of the researcher at the clinics, a short 
recruitment video of the researcher explaining the study was produced for staff to 
share with eligible patients (https://vimeo.com/374373327). 
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To supplement recruitment between January 2020 and March 2020, seven 
diabetes charity organisations in the UK identified through the Diabetes Charity 
Directory on Diabetes.co.uk (a global diabetes community website) were contacted 
via e-mail to promote the study on their website and social media accounts and to 
circulate the study flyer to their members. Of these, three leading diabetes 
organisations agreed: Diabetes UK; JDRF – the type 1 diabetes charity; and the 
InDependent Diabetes Trust (IDDT). All three organisations advertised the study on 
their websites and social media accounts (e.g. Facebook, Twitter and LinkedIn). 
Individual Diabetes UK local groups, identified through the Diabetes UK website, 
were also contacted via e-mail. Of the 127 groups e-mailed, 19 agreed to circulate the 
study to their members, three responded that they no longer meet, five responded that 
they were groups aimed at children with diabetes only, one responded that the group 
members were involved in research already, and 99 did not respond. The researcher 
attended two local group meetings in person to present the study and hand out flyers 
and PISs to interested group members. A total of 38 potential participants were 
recruited through diabetes charity organisations. 
The recruitment process including the number and reason for drop-outs are 
presented in Figure 4. In total, 297 patients were contacted regarding the study 
between October 2019 and April 2020, out of whom 63 (21.2%) were excluded based 
on an initial check against the eligibility criteria and 77 (25.9%) declined to 
participate as they were either not interested in the study or unable to commit to the 
study requirements. Of the 157 patients who showed an initial interest in the study 
and agreed to be contacted by the researcher, 28 (17.8%) did not respond to contact, 
40 (25.5%) withdrew their interest or were no longer able to commit to the study time 
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requirements, and 26 (16.6%) were excluded following a second study eligibility 
check. Overall, 63 people were recruited. 
Eligibility criteria 
All participants met the inclusion criteria of being aged 18 or over, being 
fluent in English, having a diagnosis of T1D or T2D that is treated with insulin, and 
having access to the Internet. All participants had a latest HbA1c level of 
≥64mmol/mol (indicative of suboptimal glycaemic control), which was either 
confirmed by the diabetes clinics for NHS participants or based on self-report for non-
NHS participants. 
Individuals were excluded from the study if they did not meet the inclusion 
criteria. Further exclusion criteria included: diagnosis of severe or enduring 
psychiatric disorder; diagnosis of another serious and/or life-threatening physical 
condition, significant cognitive and/or visual impairment; or, accessing psychological 
therapy at the time of commencing the study to minimise confounding variables.  
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Figure 4  
CONSORT Diagram of Participant Flow through the Study 
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Design 
The pilot study was developed in line with guidance on developing and 
evaluating complex interventions from the Medical Research Council (MRC; Craig et 
al., 2008). A randomised controlled mixed design was employed with between-
subjects randomisation to intervention (MBI or VGI) and within-subjects 
measurement of outcome measures at three time-points: pre-intervention (T1), post-
intervention (T2) and one-month follow-up (T3). 
Measures 
Sociodemographic information 
A sociodemographic questionnaire (Appendix J) was used to assess the 
baseline characteristics of the two groups and to examine whether there were any 
baseline group differences. 
Well-being Questionnaire (W-BQ28; Speight et al., 2000)  
The W-BQ28 is a 28-item measure of generic psychological well-being and 
diabetes-specific well-being (Appendix K). Items are scored on a four-point Likert 
scale where respondents indicate how much each item applies to them in the past few 
weeks from “not at all” (score of 0) to “all the time” (score of 3). The measure 
includes four general subscales (Negative Well-being, Energy, Positive Well-being 
and Generic Stress) and three diabetes-specific subscales (Diabetes-specific Negative 
Well-being, Diabetes-specific Positive Well-being and Diabetes-specific Stress). A 
diabetes-specific well-being score out of 36 can be calculated, whereby greater scores 
suggest greater diabetes-specific well-being. The scale has been shown to be a valid 
and reliable tool in evaluating new interventions with good construct validity, 
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excellent internal consistency for each subscale (α = .80-.87) and test-retest reliability 
over a year (r = ≥.79) for all combined scales (Bradley & Lewis, 1990; Speight & 
Bradley, 2002). 
Diabetes Self-Management Questionnaire (DSMQ; Schmitt et al., 2013) 
The DSMQ is a 16-item measure of self-management activities associated 
with glycaemic control for people with T1D and T2D (Appendix L). Each item is 
scored on a 4-point Likert scale from “applies to me very much” (score of 3) to “does 
not apply to me” (score of 0). The measure is composed of four subscales (Glucose 
Management, Dietary Control, Physical Activity and Health-care Use), from which a 
transformed total scale score out of 10 can be calculated, where higher scores indicate 
more effective self-management. The DSMQ has been shown to have good overall 
internal consistency (α = .84), acceptable internal consistency between subscales (α = 
.60-.77) and significant convergent correlations (r = .52-.58) with parallel scales of 
self-management (Schmitt et al., 2013). 
Diabetes Acceptance Scale (DAS; Schmitt et al., 2018) 
The DAS is a 20-item global measure of diabetes acceptance (Appendix M). 
Each item is scored on a 4-point Likert scale from “always true for me” (score of 3) to 
“never true for me” (score of 0). It is composed of two subscales (Psychological 
Acceptance/Integration and Diabetes-related Motivation), which can be summed to 
form a total score out of 60. Higher total scores indicate fewer problems related to 
diabetes acceptance.  Schmitt et al. (2018) demonstrated high factorial and criterion 
validity, as well as excellent internal reliability for the total scale (α = .95-.97) and for 
each subscale (α = .87-.94) for both T1D and T2D. The DAS has shown significant 
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convergent correlations (r = .42-.69) with parallel scales of acceptance, depressive 
symptoms, glucose monitoring, self-management, medication adherence and diabetes 
distress (Schmitt et al., 2018). 
Valued Living Questionnaire (VLQ; Wilson & DuFrene, 2009) 
The VLQ is a 20-item measure of value-based living in the past week across 
10 life domains: Family, Relationships, Parenting, Friendship, Work, Education, 
Recreation, Spirituality, Citizenship, and Physical Self-care (Appendix N). Each 
domain is rated on a ten-point Likert scale of importance and consistency, from “not 
at all important/consistent” (score of 1) to “extremely important/consistent” (score of 
10). These scores are combined to calculate a mean valued living composite score out 
of 100; greater scores indicate that the person is living life more in line with their 
values. Wilson et al. (2010) have shown satisfactory internal consistency and test-
retest reliability for the valued living composite (α = .64-.74; r = .75), and for the 
individual life domains (α = .79-.83; r = .57-.79).  
Glycaemic control 
The most common way of measuring glycaemic control is through a blood test 
that assesses glycated haemoglobin level (HbA1c). This provides a measure of 
haemoglobin molecules that have formed a bond with glucose that remains in the 
blood stream for approximately three months, indicative of an individuals’ average 
glycaemic control over the last three months. Greater HbA1c levels are indicative of 
poorer glycaemic control. Participants’ latest HbA1c level were either obtained from 
medical records or through self-report for those recruited from diabetes charity 
organisations at baseline and again at follow-up. 
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Acceptability and deliverability of interventions 
To measure the acceptability and deliverability of the interventions, the 
number of patients who participated, the response rate and the attrition rate were 
examined. At the end of the intervention, participants were asked to complete a brief 
feedback questionnaire developed for the purposes of this study to gain a better 
understanding of their views on the effectiveness, user-friendliness and relevance of 
the intervention they took part in, including whether they would recommend the 
programme to others and space to describe any difficulties they experienced during 
the programme (Appendix O). 
Interventions 
Both four-week interventions used a self-help web-based format and were 
hosted on Qualtrics, a secure online platform for conducting research. Service user 
feedback was sought from three individuals with insulin-treated T2D, four individuals 
with T1D and one carer. Overall, the feedback was that both interventions were 
simple, easy to navigate and relevant to people with diabetes. Adjustments were made 
to the examples used in the VGI and to the debriefing process. 
Values-plus-Goals Intervention (VGI) 
The VGI (Appendix P) was adapted from an existing online value-affirmation 
and goals intervention (Kingston & Ellett, 2014; Evans et al., 2019) and an existing 
programme handbook developed by Ashcroft (2014), “Living Well with Physical 
Health Conditions”. Participants were first introduced to the concept of values as 
understood in Acceptance and Commitment Therapy (ACT; Hayes et al., 1999), 
followed by a description of the relevance of values for managing diabetes. The 
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participants were then asked to complete a values-clarification card-sort task adapted 
from Harris (2008), which involved organising 10 life domain cards (“Family”, 
“Marriage/Couples/Intimate Relationships”, “Parenting”, “Friendships/Social Life”, 
“Career/Employment”, “Education/Training/Personal Growth and Development”, 
“Leisure/Recreation/Fun”, “Spirituality”, “Citizenship/Environment/Community 
Life”, and “Health/Self-care”) according to their perceived level of importance into 
one of three categories: “very important to me”, “quite important to me” and “not 
important to me”. Participants subsequently chose one value that was the most 
important and meaningful to them from the “very important to me” pile, and to 
connect with this value, they wrote about their chosen value in a text box for up to 10 
minutes, thinking about why it was meaningful to them and describing a time when it 
made them feel good about themselves (based on Sherman et al., 2000). As a 
manipulation check, participants were asked to rate four statements on a scale of 1 
(strongly disagree) to 6 (strongly agree) to assess whether they wrote about a 
personally important value that is relevant to their diabetes (Evans et al., 2019). 
Following this, participants were given information and examples on using 
values to set diabetes-related goals. They were given instructions on how to set a goal 
that is “SMART” (specific, meaningful, adaptive, realistic and time-framed) based on 
their chosen value and asked to set one for themselves to focus on over the next 
month. A second manipulation check was completed by asking participant to confirm 
that their chosen goal followed “SMART” principles, and they were asked to consider 
solutions to overcome potential barriers to achieving their goal. Thereafter, 
participants were sent a reminder e-mail every week over the four weeks, asking them 
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to reconnect with their chosen value, review their progress towards their goal and to 
reflect on the process of moving towards their goal (see example in Appendix P). 
Mindfulness-based Intervention (MBI) 
In the MBI, participants were introduced to the concept of mindfulness and 
acceptance as understood in ACT (Hayes et al., 1999), followed by a description of 
how these skills can be applied as a way of coping with challenging thoughts, feelings 
and physical sensations related to diabetes (Appendix Q). The participants were then 
presented with a recording of a ten-minute health-focused guided mindfulness 
meditation exercise read by a female clinician. The script focused on cultivating 
mindful awareness of internal experiences, particularly in relation to diabetes, and 
practising making room for any difficult internal experiences, based on scripts 
developed by Harris (2009). This exercise was followed by four prompting questions 
to promote reflections related to their diabetes following the exercise. The participants 
were asked to practise this exercise three to four times a week over a four-week 
period. As a manipulation check, participants were sent a reminder e-mail every week 
over the four weeks and asked to record how many times they practised the exercise 
over the past week on Qualtrics and to make note of their reflections on their 
experience each week (see example in Appendix Q). 
Procedure 
Figure 4 depicts the study procedure. Interested patients were asked to share 
their contact details with the researcher so they could be contacted via telephone 
and/or e-mail regarding the study and to have their questions answered. Qualtrics was 
used to host all stages of the study. Patients who confirmed their interest were sent a 
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Qualtrics link via e-mail to access the electronic version of the PIS and to complete 
the consent form to proceed with the study. Three reminders were sent to potential 
participants to complete the consent form; non-responses were interpreted as 
withdrawal of interest in the study. 
After providing informed consent, each participant was assigned a unique 
identification number to access the questionnaires and intervention on Qualtrics and 
to anonymise their responses. Participants then completed the sociodemographic 
information questionnaire, followed by the four pre-intervention questionnaires (W-
BQ28; DSMQ; DAS; VLQ) which were presented in a random order using Qualtrics’ 
randomiser function to minimise any order effects. Upon completion, they were 
automatically randomly allocated to take part in the VGI or the MBI by Qualtrics. 
During the four-week interventions, participants were sent four mid-week 
reminders to continue with their meditation practice or with pursuing their goal. They 
were also sent reminders at the end of each week to complete the weekly progress 
review. When participants did not complete their weekly review, they were sent 
further reminders by the researcher encouraging them to complete the review at their 
earliest convenience. If participants did not respond to reminders sent during this 
period, it was assumed that they had disengaged from the study. After completion of 
the fourth week progress review, participants were automatically redirected to 
complete the same set of questionnaires and asked to provide feedback on the 
intervention that they took part in. One month after intervention completion, 
participants were automatically contacted through Qualtrics to complete a final set of 
follow-up questionnaires. Participants’ latest HbA1c level was obtained from the 
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diabetes clinic or through self-report at the beginning of the study and two months 
after the end of the intervention. 
At the end of the study, participants were debriefed and given the opportunity 
to take part in the alternative intervention without further involvement from the 
researcher. 
Data analysis 
Participants were included in the analysis using a per-protocol principle, 
defined as completion of their allocated intervention and completion of outcome 
measures for at least two time-points. Given that the study was a pilot project, using 
intention-to-treat principle was not deemed appropriate; thus, participants who only 
completed pre-intervention measures and did not complete the intervention were 
excluded. Descriptive statistics were utilised to examine attrition and intervention 
adherence in each condition, and to explore the pattern of the data using means, 
standard deviations, ranges, frequencies and percentages. This was followed by 
statistical testing to identify whether any differences were statistically significant. 
Data were visually inspected for missing data. Exploratory data analysis was 
completed on all outcome and process variables to assess whether assumptions for 
parametric analysis were met. Boxplots were visually inspected to identify outliers. 
Extreme scores were identified as falling more than three standard deviations above or 
below the sample mean separated for each group and for each time-point. Extreme 
scores were retained if they reflected meaningful variation in the data and did not 
appear to have a significant impact on other data points. Histograms were visually 
inspected to examine whether outcome measures were normally distributed in each 
group condition, and cross-checked by examining skewness and kurtosis through 
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calculation of z-scores. Where skewed distributions were identified (z > 3.29, p < 
.001), transformations were used to obtain a normal distribution. 
Groups were examined for baseline equivalence in sociodemographic 
information, pre-intervention outcome measures and process measures using 
independent samples t-tests for continuous variables and chi-square tests for 
categorical variables. If the data met parametric assumptions of normality and 
sphericity, repeated measures analysis of variances (ANOVAs) with Huynh-Feldt 
correction for the degrees of freedom were used for hypothesis testing. Parametric 
analyses were conducted despite the small sample sizes based on the findings of 
Oberfeld and Franke (2012), who demonstrated that applying the Huynh-Feldt 
correction controlled the Type I error rate for small samples as long as the data is 
normally distributed. 
The first and second research questions related to investigating the impact of 
the interventions on outcome measures and process measures across the three time-
points, respectively. Hypotheses were tested using repeated measures ANOVA with 
Huynh–Feldt correction. If the ANOVA result was significant, then this result was 
decomposed using post-hoc paired-samples t-tests. Whilst Bonferonni corrections 
were considered to control the family-wise error rate, they were not applied as the 
corrected p-value was deemed to be too stringent, which increases the likelihood of 
Type II errors (Field, 2009). Given the small sample sizes, equivalent non-parametric 
tests were run for all above hypothesis-testing analyses to check their impact on the 
results. As follow-up HbA1c values were only obtained for a small number of 
participants, statistical testing was not deemed appropriate. 
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Given the small sample sizes, a post-hoc decision was made to examine 
whether the interventions had a clinically significant impact on well-being, diabetes 
self-management and HbA1c. Reliable Change Indices (RCI) were calculated for each 
participant by dividing the difference between the scores from two time-points by the 
standard error of the difference between the two scores using an Excel calculator 
made available online (Zahra, 2010). This was completed for total well-being scores 
and diabetes self-management scores across all the three time-points (T1-T2, T2-T3 
and T1-T3). If the RCI was greater than 1.96, the difference was considered reliable 
(p < .05) as a change of that magnitude would not be expected from measurement 
error alone. 
Where changes were identified as reliable, they were further examined to 
check whether they were clinically significant changes using an online calculator 
(www.psyctc.org/stats/rcsc.htm). For the W-BQ28, a change in score of 3.0 was 
considered to be clinically significant (Speight et al., 2012). For the DSMQ, raw 
subscale scores were inspected against cut-off criteria which suggest poor or 
inadequate levels of specific aspects of diabetes self-management (Schmitt et al., 
2013). A change of 5.5 mmol/mol (0.5%) in HbA1c was interpreted as clinically 
significant, as typically considered by diabetes clinicians (Lenters-Westra et al., 
2014). 
For the final set of hypotheses, related to investigating associations between 
changes in process outcomes and changes in outcome measures across the three time-
points, standard multiple linear regression were carried out, controlling for pre-
intervention scores and using unstandardised residual change scores for process 
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outcomes. All data analysis was completed using the IBM SPSS Statistics for 
Windows, Version 21.0. 
Results 
Exploratory data analysis 
Attrition 
Overall, 15 participants (55.5%) did not complete the MBI and 12 participants 
(41.4%) did not complete the VGI. Attrition rates did not significantly differ between 
the two groups, χ2(1) = 1.13, p = .289. In terms of sociodemographic characteristics, no 
significant differences were found between participants who completed and those who 
did not complete with regard to age (t(54) = 1.17, p = .247), gender (χ2(1) = 2.70, p = 
.100), ethnicity (χ2(2) = 1.57, p = .456), BMI (t(52) = .319, p = .751), diabetes type (χ2(1) 
= .626, p = .609), diabetes duration (t(54) = 1.34, p = .187), insulin treatment duration 
(t(54) = .916, p = .364), number of diabetes complications (χ2(1) = .111, p = .740) and 
additional health problems (χ2(1) = .721, p = .396). However, individuals who 
experienced a greater number of hypoglycaemic episodes in the past two months (M = 
6.48, SD = 1.33) were more likely to complete the study than those who experienced 
fewer episodes (M = 5.48, SD = 1.99), t(44.9) = 2.20, p = .033. 
With respect to outcome and process measures at baseline, no significant 
differences were found between participants who completed and those who did not 
complete with regard to valued living (t(49.7) = -.168, p = .867), diabetes self-
management (t(54) = 1.63, p = .109) and HbA1c values (t(52) = -.665, p = .509). 
However, individuals with higher levels of diabetes acceptance (M = 42.8, SD = 12.6) 
and well-being (M = 20.7, SD = 10.2) were more likely to complete the study than 
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those with lower levels of diabetes acceptance (M = 34.9, SD = 13.6) and well-being 
(M = 14.6, SD = 8.39), t(54) = 2.26, p = .028 and t(54) = 2.42, p = .019, respectively.
1  
Missing data 
In the sociodemographic questionnaire, one participant did not report their 
weight and two participants did not report how frequently they take their insulin. No 
missing data were identified in any of the measures, as participants were alerted if 
they missed any items on the questionnaires by Qualtrics. Follow-up HbA1c values 
were only collected for eight out of 29 participants (MBI: n = 3; VGI: n = 5) as the 
study relied on data from routine blood tests, and the remainder of the sample had not 
had their routine blood test at the time of data analysis. 
Outliers 
No participants were identified as outliers in terms of age, BMI, diabetes 
duration, insulin treatment duration and number of hypoglycaemic episodes in the 
past two months. Visual inspection of boxplots revealed that four participants had one 
score each that was identified as an outlier on the following questionnaires, completed 
at follow-up: DSMQ (n = 2); DAS (n = 1); and VLQ (n = 1). As the outliers were 
within three standard deviations away from the mean, they were not considered 
extreme. They were retained in the dataset as they were deemed to be reflective of 
meaningful variation in the data and they did not impact on other data. One 
participant had a pre-intervention HbA1c value that was identified as an outlier and 
almost an extreme score by a difference of 1 mmol/mol. This HbA1c value was 
                                                 
1 These statistical results were crosschecked using Mann-Whitney U tests, which yielded 
the same results. 
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excluded from subsequent analysis as it appeared to skew the distribution of the data, 
as described in the next subsection. 
Assumption of normality 
All outcome and process measures, with the exception of one measure, were 
normally distributed. A positive skew was identified in the distribution of pre-
intervention HbA1c (z = 4.01, p < .001). Applying transformations such as Box-Cox 
and Log10 did not lead to a normal distribution. Visual inspection of the histogram 
indicated that the extreme HbA1c value may be skewing the distribution. Removal of 
the extreme score led to a normal distribution (z = .51, p > .01). 
Intervention adherence 
MBI. The mean time taken to complete the MBI was 46.4 days (SD = 19.0, 
range = 30-84). Participants in the MBI condition practised the 10-minute meditation 
practice 2.94 days (SD = 1.09, range = 1-5) per week on average, completing a mean 
total of 11.8 practices (SD = 4.35, range = 4-20) over the course of the programme.  
VGI. The mean time taken to complete the VGI was 53.5 days (SD = 19.5, 
range = 29-89). Participants in the VGI conditions chose the following values as their 
top value that is most meaningful and important to them: parenting (n = 3); marriage, 
couples or intimate relationships (n = 4); family – other than marriage or parenting (n 
= 6); community life (n = 1); leisure (n = 1); health and self-care (n = 1). One 
participant chose to focus on three values (family, intimate relationships and health); 
as they were able to set a single one-month goal that spanned all three life domains, 
their data was retained in the analysis. On a scale of 1 to 6 (“strongly disagree” to 
“strongly agree”), participants rated their chosen value in terms of relevance to them 
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(M = 5.18, SD = 0.88), importance in their life (M = 5.24, SD = 0.83), how much they 
try to live up to the value (M = 5.18, SD = 0.95) and how much the care about it (M = 
5.47, SD = 0.94). All participants set a goal that they considered specific and 
achievable in the next month and relevant to their diabetes self-management. All 
participants, except four, reported that their goal was consistent with their chosen 
value. At the end of the programme, 12 participants reported that they had been able 
to move towards their goal, one participant reported that their goal was no longer 
applicable at present due to the impact of COVID-19, and four participants were not 
able to move towards their goal due to the impact of COVID-19 (n =2), Christmas (n 
= 1) and external circumstances outside of their control (n = 1). 
Intervention feedback 
MBI. On a scale of 1 to 10, on average participants rated the MBI programme 
as somewhat helpful (M = 6.33, SD = 2.90), relevant to them (M = 5.92, SD = 2.84) 
and easy to use (M = 5.92, SD = 2.84). They rated the length of the programme as 
satisfactory (M = 7.92, SD = 1.44) and 10 out of 12 participants stated that they would 
recommend the programme to a friend with diabetes. 
VGI. On a scale of 1 to 10, on average participants rated the VGI programme 
as somewhat helpful (M = 6.41, SD = 2.60), relevant to them (M = 6.53, SD = 3.04) 
and very easy to use (M = 9.00, SD = 1.22). They rated the length of the programme 
as satisfactory (M = 7.88, SD = 1.76) and nine out of 17 participants stated that they 
would recommend the programme to a friend with diabetes. 
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Baseline equivalence between groups  
No significant differences in sociodemographic characteristics (see Appendix 
F, Table F1), and pre-intervention outcome and process measures (see Appendix F, 
Table F2) were found between the two conditions using independent samples t-tests 
and chi-square tests.2 
Hypothesis testing 
The means and standard deviations of scores across the three time-points for outcome 
and process measures, alongside the Huyhn-Feldt corrected results of the repeated 
measures ANOVAs, are presented in Table 4.3 
                                                 
2 These statistical results were repeated using Mann-Whitney U tests, which obtained the 
same results. 
3 All repeated ANOVAs and paired sample t-tests were crosschecked using Friedman 
tests and Wilcoxon Signed-Rank tests, which yielded the same results. 
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Table 4  
Means and Standard Deviations of Study Variables across Time and Results of Repeated Measures ANOVAs 
Study Variable / 
Time –  M (SD) 
MBI (n = 12)  VGI (n = 17)  Full Sample (N = 29)  
Test Statistic 
T1 T2 T3  T1 T2 T3  T1 T2 T3  
Diabetes self-
management  
6.79 
(1.46) 
7.08 
(1.56) 
7.47 
(1.60) 
 
6.40 
(1.46) 
7.10 
(1.25) 
7.44 
(1.36) 
 
6.56 
(1.45) 
7.09 
(1.36) 
7.46 
(1.42) 
 VGI: F(1.47, 14.7) = 3.69,  
          p = .061, ηp2 = .270 
MBI: F(1.90, 13.3) = .749,  
          p = .485, ηp2 = .097 
Well-being 
22.8 
(9.94) 
24.3 
(8.23) 
26.1 
(9.30) 
 
19.2 
(10.4) 
20.9 
(7.86) 
23.1 
(9.05) 
 
20.7 
(10.2) 
22.3 
(8.04) 
24.4 
(9.03) 
 VGI: F(1.62, 16.2) = .933,  
         p = .395, ηp2 = .085 
MBI: F(1.63, 11.4) = .667,  
         p = .503, ηp2 = .087 
HbA1c
a 
75.6 
(7.62)b 
N/A 
67.0 
(8.41) 
 
77.9 
(10.5) 
N/A 
64.0 
(7.18) 
 
77.0 
(9.39) 
N/A 
64.4 
(10.8) 
 VGI: N/A 
MBI: N/A 
Valued living 
51.1 
(20.8) 
55.8 
(16.8) 
49.1 
(14.9) 
 
43.3 
(22.4) 
47.8 
(22.7) 
54.6 
(19.2) 
 
46.5 
(21.7) 
51.1 
(20.5) 
52.3 
(17.3) 
 VGI: F(2, 20) = 1.82,  
         p = .188, ηp2 = .154 
MBI: F(2, 14) = 2.13,  
         p = .155, ηp2 = .234 
Diabetes 
acceptance 
46.1 
(10.2) 
47.0 
(10.3) 
50.5 
(8.78) 
 
40.4 
(13.9) 
43.1 
(10.3) 
46.2 
(11.7) 
 
42.8 
(12.6) 
44.7 
(10.3) 
48.0 
(10.5) 
 VGI: F(2, 19.9) = .724,  
         p = .497, ηp2 = .068 
MBI: F(1.53, 10.7) = .347,  
         p = .659, ηp2 = .047 
Note. a Follow-up HbA1c values were obtained for n = 2 in the MBI group and n = 5 in the VGI group. Due to the small sample sizes, 
statistical tests were not conducted for HbA1c; 
b Based on n = 11 following removal of outlier 
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Research Question 1 – Impact of interventions on outcome measures 
Hypothesis: Well-being will be significantly greater at post-intervention 
and follow-up than at pre-intervention in the MBI condition. The means indicated 
an increase in well-being scores from pre-intervention to post-intervention, and from 
pre-intervention to follow-up in the MBI condition. However, a repeated measure 
ANOVA revealed no statistical significant differences in well-being scores over time 
(see Table 4). 
Reliable Change Indices and Clinically Significant Changes. Two 
participants (16.7%) in the MBI condition were identified as having shown a reliable 
pre-post improvement in their well-being scores, obtaining RCI values of 2.09 and 
2.47 (p < .05). Both changes in scores (+11 and +13 respectively) were greater than 
3.0, indicating that they were clinically significant. Follow-up data was not obtained 
for one of these participants; the other participants did not show a reliable 
improvement in their well-being score between pre-intervention and follow-up (p > 
.05), suggesting that the reliable pre-post improvement was not maintained at follow-
up. Reliable improvements in well-being were not identified in the remainder of 
participants in the MBI condition (see Table R1, Appendix R). 
Hypothesis: Self-reported diabetes self-management activities will have 
significantly improved at post-intervention and follow-up compared to pre-
intervention in the VGI condition. A repeated measures ANOVA identified a non-
significant positive trend in the diabetes self-management scores across the three 
time-points, F(1.47, 14.7) = 3.69, p = .061, ηp2 = .270. As the p-value indicated that 
the intervention effect was close to being statistically significant, post-hoc analyses 
were run using paired samples t-tests to decompose the effect. These revealed a 
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significant pre-post increase in diabetes self-management, t(16) = -2.96, p = .009, d = 
.504. No significant differences in diabetes self-management were identified between 
pre-intervention and follow-up (t(10) = -1.96, p = .079, d = .474), and post-intervention 
and follow-up (t(10) = -.113, p = .912, d = .013). The calculated d-statistics would be 
considered medium effect sizes for pre-intervention to post-intervention, and for post-
intervention to follow-up (Cohen, 1988). However, these results should be interpreted 
with caution due to the small sample and given that the overall finding did not reach 
statistical significance.  
Post-hoc analyses of DSMQ subscales were run to explore the impact of the 
interventions on different aspects of diabetes self-management over time in the VGI 
condition. Repeated measures ANOVAs indicated no significant differences in 
glucose management (F(1.54, 15.4) = .966, p = .381, ηp2 = .088), physical activity 
(F(2, 20) = .907, p = .420, ηp2 = .083) and physician contact (F(1.64, 16.4) = .56, p = 
.549, ηp2 = .053) across the three time-points. However, the a significant effect of time 
on dietary control was identified (F(1.59, 15.9) = 6.98, p = .01, ηp2 = .411), with post-
hoc t-tests revealing a significant improvement in dietary control between pre-
intervention (M = 4.71, SD = 2.58) and post-intervention (M = 5.88, SD = 2.14) (t(16) = 
-3.23, p = .005, d = .478), and between pre-intervention and follow-up (M = 6.74, SD 
= 2.70) (t(10) = -2.75, p = .020, d = .46). No significant differences were found 
between post-intervention and follow-up dietary control (t(10) = -.762, p = .464, d = 
.081). Overall, these results suggest that participants in the VGI condition experienced 
a significant pre-post improvement in their dietary control, which was maintained at 
follow-up. 
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Reliable Change Indices and Clinically Significant Changes. Four 
participants (23.5%) were identified as having shown a reliable pre-post improvement 
in their diabetes self-management scores, obtaining RCI ranging from 2.02 and 3.03 
(p < .05). Follow-up data was not obtained for two of these participants. One 
participant showed a reliable improvement in their diabetes self-management score 
between pre-intervention and follow-up (RCI = 2.27, p < .05), suggesting that the 
reliable pre-post improvement was maintained at follow-up. One participant did not 
show a reliable improvement in their diabetes self-management score between pre-
intervention and follow-up (p > .05), suggesting that the reliable pre-post 
improvement was not maintained at follow-up. One additional participant did not 
show a reliable pre-post improvement, but showed a reliable improvement from pre-
intervention to follow-up (RCI = 3.28, p < .05). Reliable improvements in diabetes 
self-management were not identified in the remainder of participants in the VGI 
condition (see Table R2, Appendix R). 
Inspection of the DSMQ subscale scores revealed that participants in the VGI 
condition did not obtain scores that indicated poor glucose management (raw score 
below 5) or poor adherence to diabetes-related physician contact (raw score below 3) 
at pre-intervention, and their scores remained above the clinical cut-off criteria at 
post-intervention and follow-up for these two subscales. With regard to dietary 
control, four participants in the VGI condition were identified as having poor dietary 
control (raw score below 4) at pre-intervention. Three of those participants showed 
clinically significant improvements in their dietary control at post-intervention; their 
follow-up data was not obtained. One participant’s scores indicated that they 
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experienced no clinically significant improvement in their dietary control over the 
course of the study. 
Six participants were found to have poor levels of physical activity (raw score 
below 3) at pre-intervention, out of whom one participant showed a clinically 
significant improvement at follow-up and four participants did not show clinically 
significant improvement over time. Four additional participants at post-intervention 
and two participants at follow-up indicated that they had dropped to a suboptimal 
level of physical activity. One of these participants showed a clinically significant 
improvement from post-intervention to follow-up. However, follow-up data was not 
available for four participants. 
Hypothesis: Glycaemic control will have significantly improved at follow-
up compared to pre-intervention in the VGI condition. Due to the small sample 
size, a paired samples t-test was deemed inappropriate for assessing change in HbA1c. 
Four out of five participants in the VGI condition showed clinically significant 
improvements in their HbA1c between pre-intervention and follow-up, with reductions 
in HbA1c ranging from 8 to 28mmol/mol (see Table R3, Appendix R). 
Research Question 2 – Impact of interventions on process measures 
Hypothesis: The MBI will be associated with increased diabetes 
acceptance at post-intervention and follow-up, whilst the VGI will be associated 
with increased valued living at post-intervention and follow-up. As shown in 
Table 4, the mean scores for diabetes acceptance indicated an improvement from pre-
intervention to post-intervention, and from post-intervention to follow-up in the MBI 
condition. However, a repeated measures ANOVA identified no significant difference 
109 
 
in diabetes acceptance scores over time. In the VGI condition, the mean scores for 
valued living showed an improvement from pre-intervention to post-intervention, and 
from post-intervention to follow-up, although a repeated measures ANOVA did not 
identify a significant difference in valued living scores over time. 
Research Question 3 – Associations between changes in outcome measures and 
process measures 
Hypothesis: In the MBI group, improvement in self-reported well-being 
at post-intervention and follow-up will be associated with an increase in diabetes 
acceptance. Separate standard multiple linear regressions were performed with post-
intervention and follow-up well-being as the dependent variables, and pre-
intervention well-being and the pre-post change in diabetes acceptance as independent 
variables, in the MBI group. These two variables accounted for a significant amount 
of variance in post-intervention well-being (R2 = .826, adjusted R2 = .788; F(2,9) = 
21.4, p < .001) and in follow-up well-being (R2 = .957, adjusted R2 = .939; F(2,5) = 
55.3, p < .001). However, given the small sample size, the high R2 values may 
indicate an overfit regression model. The partial regression coefficients showed that 
pre-intervention well-being was independently associated with post-intervention well-
being (B = .700, β = .846, t(9) = 6.09, p < .001) and follow-up well-being (B = .832, β 
= .966, t(5) = 10.1, p < .001). The pre-post change in diabetes acceptance was 
independently associated with post-intervention well-being, after controlling for pre-
intervention well-being, B = .413, β = .341, t(9) = 2.45, p = .037. The changes in 
diabetes acceptance between pre-intervention and follow-up was not independently 
associated with follow-up well-being, after controlling for pre-intervention well-
being, B = .114, β = .047, t(5) = .491, p = .644. 
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Hypothesis: In the VGI group, improvement in self-reported diabetes 
self-management activities and glycaemic control at post-intervention and 
follow-up will be associated with an increase in valued living. The small sample 
size available for HbA1c precluded the use of multiple regression to assess 
associations between changes in HbA1c and changes in valued living. Separate 
standard multiple regressions were performed with post-intervention and follow-up 
diabetes self-management as the dependent variables, and pre-intervention diabetes 
self-management and the pre-post change in valued living as independent variables, in 
the VGI group. These two variables accounted for a significant amount of variance in 
post-intervention diabetes self-management (R2 = .567, adjusted R2 = .505; F(2,14) = 
9.16, p = .003) and follow-up diabetes self-management (R2 = .523, adjusted R2 = 
.404; F(2,8) = 4.38, p = .052). This result may have been due to overfitting of the 
regression model. The partial regression coefficients showed that pre-intervention 
diabetes self-management was independently associated with post-intervention 
diabetes self-management (B = .647, β = -.005, t(14) = 4.24, p = .001) and with follow-
up diabetes self-management (B = .708, β = .702, t(8) = 2.86, p = .021). However, 
post-intervention valued living was not independently associated with either post-
intervention diabetes self-management or follow-up diabetes self-management, after 
controlling for pre-intervention diabetes self-management, t(14) = -.029, p = .977, and 
t(8) = 1.04, p = .330 respectively. 
Discussion 
The present study has contributed to the literature by exploring the impact of 
two four-week online interventions based on ACT components (mindfulness and 
acceptance, and values and committed action) as potential ways of addressing the 
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need for accessible and financially feasible psychological interventions to support 
individuals with insulin-treated diabetes and suboptimal glycaemic control. 
Differential intervention effects were hypothesised based on the proposed theoretical 
mapping of ACT processes on the CSM for understanding illness self-regulation 
(Karekla et al., 2018). 
Key findings 
Mindfulness-based Intervention 
Karekla and colleagues (2018) suggested that ACT concepts of mindfulness, 
cognitive defusion and acceptance could help individuals to recognise inner 
experiences as they are and provide ways to deal with difficult thoughts. The present 
study hypothesised that diabetes acceptance could be considered a form of emotion-
focused coping style that could influence emotional outcomes. 
The hypothesis that individuals in the MBI group would report greater well-
being and diabetes acceptance at post-intervention and follow-up, was not supported. 
Participants experienced non-significant improvements in their well-being and 
diabetes acceptance over time, with only two out of 12 participants experiencing 
clinically significant improvements in their well-being. As hypothesised, participants’ 
post-intervention well-being was significantly associated with changes in diabetes 
acceptance, after controlling for baseline well-being. However, well-being at follow-
up was only linked with participants’ baseline well-being, suggesting that the impact 
of the MBI was not substantial enough to make a difference in the long-term. 
One reason behind the non-significant association between the MBI and well-
being might have been because diabetes acceptance did not significantly improve over 
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time. This finding contrasted with previous findings that ACT-based interventions led 
to improvements in diabetes acceptance (e.g. Gregg et al., 2007; Shayeghian et al., 
2016; Welch, 2014; Whitehead et al., 2017). Differences in measurement may explain 
this discrepancy as previous studies utilised the Acceptance and Action Diabetes 
Questionnaire (AADQ; Gregg et al., 2007), whereas the DAS was used in the present 
study due its superiority as a theory-driven questionnaire (Schmitt et al., 2014). 
Further, a recent systematic review conducted by Medina and colleagues (2017) 
indicated that the impact of mindfulness-based interventions on diabetes acceptance 
has not yet been established and requires more controlled studies. 
Another explanation for the non-significant finding in diabetes acceptance 
could equally have been due to the potential shortfalls in the format, content and 
length of the MBI. Participants reported that on average they completed less 
mindfulness practices than recommended, which may have reduced the impact of the 
intervention. Home practice can be influenced by factors such as motivation, 
perceived difficulty, understanding of the rationale and perceived benefits versus 
effort (Dunn et al., 2002). However, even brief mindfulness-based interventions have 
been shown to yield significant positive effects on health outcomes (Lloyd et al., 
2018). A confounding factor could have been the quality of the mindfulness practices. 
Individuals’ level of engagement with the practice could have been influenced by 
several factors which were not measured, including participants’ prior experience of 
and expectations from mindfulness and factors such as levels of discipline, fatigue, 
stress and distractions in the environment. 
Furthermore, Schmitt et al. (2018) found that the longer an individual’s 
diabetes duration, the greater their diabetes acceptance. Given that the average 
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diabetes duration of the sample was 21.9 years, it may be that diabetes acceptance was 
not the appropriate target for improving well-being in this sample. In line with this, 
none of the participants obtained scores indicative of low diabetes acceptance and 
some provided feedback that they had felt that they would have benefited more from 
the MBI at the point of diagnosis. 
Moreover, the relationships between mindfulness, diabetes acceptance and 
well-being are not clear cut. Some individuals with low diabetes acceptance may be 
less emotionally impacted by their diabetes due to the short-term relief associated 
with experiential avoidance (Schmitt et al., 2014). It was expected that diabetes 
acceptance would increase through reducing experiential avoidance, which could then 
improve well-being. On the contrary, facing one’s experience of diabetes can result in 
being reminded of the possibility of complications despite good treatment adherence, 
which may increase awareness of difficult internal experiences around the futility of 
adhering to treatment and self-management strategies (McCracken et al., 2010). 
However, experiential avoidance was not measured so it is difficult to identify its 
relationship with acceptance and well-being. 
It is possible that well-being did not improve because of its associations with 
factors other than diabetes acceptance, as it is a broad and complex construct that 
incorporates concepts such as positive affect, self-efficacy and gratitude (Ryan & 
Deci, 2001). Thus, the lack of significant findings could relate to the MBI’s shortfalls 
in targeting individual barriers to well-being by people with diabetes. It could also 
have been a reflection of confounding variables that may have hindered well-being 
such as the impact of external factors such as the impact of COVID-19 and significant 
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life events that were not controlled for, as emotional and psychological needs can be 
greater during these periods (Diabetes UK, 2010). 
Values-plus-Goals Intervention 
Karekla and colleagues (2018) proposed that the ACT components of 
clarifying personal values, setting goals consistent with values and committing to take 
action enable behaviour change through empowering individuals and reinforcing why 
the behaviour change is important to them. It was hypothesised that individuals who 
took part in the VGI would report improvements in their diabetes self-management, 
glycaemic control and valued living following the intervention and at a four-week 
follow-up. 
The hypotheses were partially supported. Participants showed a non-
significant positive trend in their diabetes self-management, reporting improvements 
of medium effect size in their diabetes self-management post-intervention, which was 
maintained at follow-up. Interestingly, only the dietary control component of self-
management significantly improved over time with three participants reporting 
clinically significant improvements. No significant changes were noted in 
participants’ glucose management, physical activity or physician contact. Contrary to 
the hypotheses, the improvement in valued living over time was non-significant, and 
changes in valued living and diabetes self-management over time were not 
significantly associated when baseline diabetes self-management was controlled for. 
Although the HbA1c data was not analysed due to the small sample, four 
participants had reduced HbA1c levels at follow-up, which was consistent with 
existing literature. Positive trends in glycaemic control have been identified following 
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ACT interventions, including Gregg and colleagues (2007) who found an 
improvement in individuals’ diabetes control status. Further, the individual 
improvements observed appeared greater than the mean improvement observed by 
Winkley and colleagues (2020b) in their meta-analysis of CBT-based interventions; 
thus, this finding requires replication in a larger sample. 
It is likely that the marginal, but non-significant improvement in diabetes self-
management was due to the study being underpowered. The finding was broadly 
consistent with previous research which has shown improvements of small to medium 
effect size or a positive trend in individuals’ diabetes self-management following 
ACT-based interventions (Gregg et al., 2007; Shayeghian et al., 2016; Welch, 2014; 
Whitehead et al., 2017). However, post-hoc analyses revealed that the VGI 
significantly improved diet alone. On the contrary, Welch (2014) found that their 
ACT intervention significantly increased exercise and foot care but had no impact of 
diet and blood glucose testing. These differences could be explained by clinical 
differences between the samples though, as Welch’s sample had a shorter average 
diabetes duration of two years. 
It is possible that ceiling effects prevented participants’ glucose management 
and physician contact from improving if they were not problematic at baseline. It is 
also possible that improvements in diet were observed because this is an area of 
diabetes self-management that individuals have more control over. Examining 
participants’ qualitative feedback in the weekly progress reviews revealed that some 
participants were not able to improve their physical activity due to external 
circumstances such as the impact of COVID-19, holiday seasons, deterioration in 
health and an increase in stress related to changes in life circumstances, in line with 
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literature on common barriers to diabetes self-management (e.g. Ahola & Groop, 
2012; Vijan et al., 2004). Chew and colleagues (2018) identified three types of 
problems that can impact on disease control: problems with values, cognitions and 
emotions and/or motivation. Whilst the VGI attempted to increase valued living, it is 
possible that the other factors were stronger barriers in this sample; perhaps future 
studies need to focus more on overcoming these. 
The impact of VGI needs to be investigated more robustly before causal 
inferences can be made due to the small sample size and confounding factors that 
were not controlled, such as treatment regime and motivation level. Adu and 
colleagues (2019) found that individuals’ will to prevent diabetes complications 
enabled good diabetes self-management. In the present study, participants who 
experienced more hypoglycaemic episodes were more likely to complete the study. It 
may be that the potential to reduce the incidence of hypoglycaemia through improved 
self-management and glycaemic control was a motivating factor. 
Contrary to expectations, valued living did not significantly improve over 
time, and there was no association between changes in diabetes self-management and 
valued living. This contrasted with the findings of Ryan and colleagues (2019) who 
reported an increase in valued living following a 10-week ACT intervention. It may 
be that a longer, more intensive intervention is needed for improving valued living in 
this population. Some participants did not spend 10 minutes connecting with their 
value as requested so it is possible that the task did not support participants to clarify 
and connect with their chosen value. Alternatively, given that participants were asked 
to focus on one top value and valued living was measured across 10 life domains, this 
may have resulted in reduced sensitivity to detect change. Focusing on valued life 
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domains (e.g. health, relationships) instead of valued personal characteristics (e.g. 
self-development, responsibility) might have influenced the results as they have 
shown to have differential impact (Stapel & van der Linde, 2011). The variance in 
individuals’ SMART goals may have contributed towards the non-significant results 
(Schreurs et al., 2003); for example, one participant set a goal to reduce their HbA1c in 
one month, which did not fulfil all criteria of “SMART” goals.  
Strengths and limitations 
The strengths of the study included successful randomisation of participants, 
using validated and standardised measures and inclusion of a one-month follow-up, 
although the long-term impact of the interventions remain unclear. As participants 
completed baseline questionnaires before random allocation to a condition, temporal 
causality could be examined, albeit with caution. The study also had several 
limitations. An overarching issue was the small sample sizes obtained as the observed 
power of the study was between .089 and .514, indicating that the study was 
underpowered to detect differences in outcomes over time. The increased risk of type 
II errors is likely to have contributed to the statistical non-significance of the findings 
and limits the conclusions that can be drawn from the study. The power analysis also 
underestimated the sample size required as the effect sizes observed in the study were 
smaller than predicted. Caution must be taken when interpreting the obtained effect 
sizes given the small sample size. The multiple linear regressions may have been 
affected by the problem of overfitting due to attempts to estimate multiple parameters 
with small samples of observations. This can lead to biased results in the form of 
inflated R2 values, regression coefficients and p-values which may be misleading and 
specific to the analysed data set, reducing its generalisability beyond the present study 
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(Babyak, 2004). Further, conducting subgroup analysis and multiple analyses with 
small sample sizes have statistical limitations. Bonferroni corrections were not 
applied as the p-value would have been too stringent, increasing the risk of rejecting 
meaningful differences. However, this has implications when interpreting the findings 
due to the increased likelihood of type I errors (Perneger, 1998). 
Besides the impact of small samples, the generalisability of the results is 
limited by the characteristics of the sample. The sample consisted of primarily adults 
with T1D (76%) fluent in spoken English, who were primarily from White ethnic 
backgrounds and were computer literate. Thus, it is unlikely to be representative of 
the T2D population and generally the wider and more diverse diabetes population. 
Further, the results indicated that individuals with higher levels of diabetes acceptance 
and well-being, and those who experience more hypoglycaemic episodes, were more 
likely to take part in the interventions, raising the possibility of bias, as it is possible 
that individuals who may be more affected by and/or motivated to improve their 
diabetes-related outcomes may have been captured in the study. 
With regard to outcome measures, the use of self-report had limitations by 
increasing the risk of imprecision (e.g. for self-reported HbA1c values and progress 
checks) and bias, which may bring the validity of the findings into question. Whilst 
using web-based interventions had advantages such as ease of access and reducing the 
need for therapist input, it also meant that factors such as participants’ level of 
engagement, intervention compliance and attrition rates were not controlled, which 
may have influenced the results. The high attrition rate of 48.2% may been due to 
several factors based on qualitative feedback from participants, such as experiencing 
technical issues, feeling demotivated due to preconceived notions about the 
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effectiveness of an intervention incorporating mindfulness, perceiving the 
intervention as too intensive and no longer being able to commit to completing the 
intervention. Further potential confounding variables include sociodemographic 
characteristics, fatigue or loss of interest over time, the impact of individuals’ 
treatment regimes, and the impact of COVID-19 in the last two months of data 
collection. As the interventions were designed as standalone self-help programmes, 
participants only received feedback via automated standardised messages built into 
the programmes. The lack of personalised feedback and contact with a therapist may 
have had an impact on participants’ level of engagement and the attrition rate.  
The pilot study broadly followed the MRC guidance on developing and 
evaluating interventions through using a theoretical basis to develop the interventions, 
providing clear descriptions of interventions and methodology to enable study 
replication and using a range of outcome measures, including process measures (Craig 
et al., 2008). Accessibility and acceptability of the interventions and study procedure 
were verified in consultation with service users. However, smaller-scale piloting to 
test and refine the interventions and study procedure were not conducted due to time 
restraints. A process evaluation was also omitted which could have helped to gain a 
better understanding of the impact of the interventions and contextual factors that may 
have influenced intervention delivery, mechanisms and outcomes (Craig et al., 2008). 
A process evaluation would have been helpful due to the unforeseen implementation 
challenges such as recruitment barriers and high attrition rates, which resulted in the 
assumptions about rates of recruitment and retention not being met. It would have also 
helped to more accurately estimate important parameters such as effect sizes, which 
were unknown due to the novelty of the interventions (Craig et al., 2008). 
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Implications and recommendations for future research 
To our knowledge, this is the first pilot study to investigate the impact of 
interventions based on key components of the ACT model in improving the diabetes-
related outcomes of individuals with insulin-treated diabetes. Despite the study 
limitations, the findings have contributed to the literature on implementing web-
based, ACT component-based interventions generally, a relatively under-researched 
field. Understanding the impact of individual components can also build a better 
understanding of the underlying mechanisms in ACT. 
Although there is a long way to go in addressing the psychosocial needs of 
individuals with diabetes, the pilot study indicated promising results in relation to 
diabetes self-management, dietary control and glycaemic control. Feedback from 
participants suggested that overall they found the interventions feasible, accessible 
and relevant. Further research is needed to determine whether the interventions have 
potential to reliably improve diabetes-related outcomes, which could subsequently be 
used to support individuals with diabetes with their health and well-being, in addition 
to existing treatment regimens.  
The study has highlighted important avenues for future research. Firstly, it is 
recommended that the study is replicated with a greater sample size with a longer 
follow-up period to obtain the appropriate statistical power and to determine the long-
term benefit of the interventions. It is important that future studies control for 
potential confounding variables to allow comparison of the precise impact of each 
intervention component on specific diabetes-related outcomes. The timing of the 
intervention is pertinent due to the impact of external factors such as holiday seasons, 
and should be considered. Further, incorporating ways of monitoring treatment 
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adherence such as the quality of mindfulness-based practice are recommended using 
standardised tools such as the Practice Quality-Mindfulness (Del Re et al., 2013) and 
Mindfulness Home-Practice Monitoring Form (Lloyd et al., 2018). Finally, 
mechanisms of change should be formally investigated to gain a better understanding 
of how the interventions work. 
Participants’ level of engagement and intervention adherence is likely to have 
been affected by the lack of therapist contact, feedback and support in the 
interventions. Goal-setting theory emphasises the role of feedback in tracking 
progress (Locke & Latham, 1990). Thus, personalised checks through telephone 
contact may enhance engagement with and adherence to the content of the 
intervention, as well as support reflection. However, Cavanagh and colleagues (2014) 
suggested that self-help programmes can be effective in their own right. Peyrot and 
Rubin (2007) reinforced the need for incorporating a relapse prevention plan, given 
that even if an intervention is brief, diabetes remains a chronic condition.  
The study has highlighted the importance of considering the relevance and 
benefit of interventions for individuals. It is not only important to consider whom the 
interventions are appropriate for, but also to gain a better understanding of barriers to 
well-being and diabetes self-management. Targeting these may enhance the clinical 
benefit of the interventions. To reduce attrition, the drop-out rates highlight the 
importance of assessing individuals’ readiness to take part in a self-help intervention 
by exploring and targeting potential barriers to change. This could be achieved 
through individuals having face-to-face conversations with a diabetes clinician as a 
primer, before offering a self-help intervention such as the VGI or MBI. Motivational 
interviewing techniques could be used to help resolve individuals’ ambivalence and to 
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explore and address any preconceived notions about the helpfulness of psychological 
interventions (Rollnick et al., 2008). Furthermore, the reduced participant rates in 
individuals with lower hypoglycaemic episodes, lower well-being and lower diabetes 
acceptance suggest that these factors could be screened by clinicians using 
questionnaires to identify individuals who may benefit from additional support to 
maintain their engagement with the interventions. Individuals who experience more 
hypoglycaemic episodes may require more practical advice from the diabetes clinics 
in the first instance to improve their diabetes regime. Some researchers argue that 
illness perceptions can influence adjustment to diabetes, which may subsequently 
influence diabetes acceptance (Schmitt et al., 2014; Weinman et al., 1996). Thus, 
targeting illness perceptions may be a place to start for those with low levels of 
diabetes acceptance. However, engagement is harder to build via online platforms, so 
perhaps this could be something that diabetes teams offer within routine 
appointments. 
Tailoring the interventions would increase their relevance. Karekla and 
colleagues (2018) suggested ways in which ACT can target all aspects of the 
Common Sense Model such as the role of the self-system, outlining that it was 
important for interventions to assess patients’ cognitive and emotional representations 
about their condition with an emphasis on which behaviours they typically use to 
regulate these representations, and to support patients to understand the connections 
between these inner experiences, their behaviour and their adaptation to the condition. 
These steps were not included in either intervention due to the lack of therapist 
contact to support this process but could be investigated in future studies. 
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The implementation of web-based programmes has the potential to expand 
access to psychological input and to potentially improve diabetes self-management, 
which in turn may reduce complications and result in cost-savings for the NHS. This 
research could be of value to commissioners who aim to provide services that meet 
the psychological needs of people with diabetes. 
Conclusion 
Overall, the study did not support the hypothesis that the MBI would increase 
the well-being of individuals with insulin-treated diabetes and partially supported the 
hypothesis that the VGI leads to increases in diabetes self-management, although this 
was found to be specific to dietary control. Promising improvements were identified 
for glycaemic control although statistical analysis was not completed. Changes in 
diabetes acceptance were associated with changes in well-being in the MBI, but 
changes in valued living were not associated with changes in diabetes self-
management in the VGI. Given the drawbacks of the interventions and study 
methodology, further research is necessary to gain more insight into the clinical 
benefits of these interventions. 
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IV. Integration, impact and dissemination 
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Integration 
My interest in investigating ACT-based interventions for supporting people 
with diabetes stemmed from my desire to gain a better understanding of the 
differential impact of ACT components and the processes involved in conducting an 
RCT. Whilst there is a theoretical basis for supporting people with long-term 
conditions such as diabetes using ACT, it became apparent that this is often not 
available to patients due to a lack of funding and access to diabetes-specific 
psychological support (Askew & Solomons, 2019). The empirical study aimed to 
address the need for a cost-effective and feasible psychological intervention for this 
population by incorporating technology and the use of modular interventions to 
deliver ACT (e.g. Nes et al., 2012; Villatte et al., 2015).  
To ensure that our adapted interventions had a theoretical basis, our 
hypotheses were informed by the proposed links between the ACT model and the 
CSM (Karekla et al., 2018). Given the lack of data on effect sizes for the chosen 
interventions, a pilot study was used to explore the impact of the interventions, 
understand potential mediating factors and establish the number of participants 
needed for a full RCT. Whilst pilot studies typically investigate the acceptability and 
feasibility of novel interventions, they can also be used to advance knowledge on the 
underlying mechanisms of interventions and to inform future RCTs for further 
effectiveness testing (Leon et al., 2011; National Institute of Mental Health, 2009).  
Due to the doctoral course timetable, a focussed literature search was 
conducted to inform the empirical study, prior to the systematic review. On reflection, 
completing the systematic review earlier would have ensured that the study could 
address more of the issues identified. The review topic was chosen after discovering 
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that most of the articles in the ACT for diabetes field were similar, often employing 
quasi-experimental designs comparing ACT against a control condition. As no 
systematic review had been completed, the aim was to summarise existing literature 
by exploring the characteristics of ACT interventions for diabetes and examining 
whether ACT improves diabetes-related outcomes. 
The systematic review revealed a lack of quantitative research into ACT 
interventions for people with T1D. This was surprising given the significant 
psychological burden in this population. In hindsight, I wonder if it would have been 
more appropriate to investigate the effectiveness of ACT in the T1D population 
before investigating the impact of ACT components. Nevertheless, this thesis has 
contributed to the ACT for T1D literature and is the first to have examined ACT 
components.  
A challenging aspect of the systematic review was the substantial 
heterogeneity associated with the psychological outcomes. This made cross-study 
comparisons difficult and led me to conduct a narrative synthesis, which had the 
disadvantage of vote-counting, therefore weakening my conclusions (Siddaway et al., 
2019). Promisingly, there was evidence of a beneficial effect of ACT on diabetes self-
management and a mixture of psychological outcomes, particularly in T2D. This 
supported my choice to investigate key diabetes outcomes such as diabetes self-
management, well-being and HbA1c. Interestingly, the HbA1c results were mixed in 
the systematic review. However, I noticed that the more robust studies did not find 
significant changes in HbA1c. On reflection, the clinically significant reductions in 
HbA1c observed in the empirical study may have been due to the methodological 
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issues, reinforcing the need for robust studies to ascertain the impact of ACT on 
HbA1c.  
A common theme identified in this area of research was reporting bias. To 
address this, I laid out the attrition and intervention details in my study transparently. 
The systematic review highlighted a need for high-quality RCTs with active controls 
that are powered to detect significant changes. As a result, I aimed to use an active 
control and attempted to reach an appropriate sample size. However, I underestimated 
levels of attrition due to lack of information in previous studies. This led to a smaller 
sample size than intended and an underpowered study.  
The study findings suggest that modular ACT interventions may be able to 
improve diabetes self-management and dietary control. However, it appears that they 
may not be able to influence well-being, which raises the question of how we can 
improve this. Furthermore, diabetes acceptance and valued living did not increase 
significantly, suggesting that these processes may not be driving the changes 
observed. As the review examined ACT interventions and not ACT components, it is 
difficult to put the results into the context of the prevailing literature. Overall, the 
systematic review confirmed the novel aspects of the empirical study, which were: 
investigating specific ACT components, including both T1D and T2D populations, 
and including an active control group. These changes aimed to improve on previous 
studies and extend the literature with a view to facilitating real-life application. 
Reflections on recruitment 
Delays in receiving NHS ethics approval and time restraints of the project 
meant I was not able to conduct a pilot of the study procedure. Thus, I went through a 
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process of trial-and-error, adjusting my expectations of the project accordingly. 
Piloting the study would have been beneficial to gain a better understanding of 
recruitment challenges and to identify ways to overcome these. 
There were several barriers to recruitment. One of these factors was a lack of 
platform to present the study to the consultants who could facilitate recruitment. In 
response to this, I tried to speak to them at their clinics and created a brief information 
pack to support recruitment. Short appointment times and high patient turnover in 
clinics meant that staff were limited in their ability to assist with recruitment. To 
enable a rapid recruitment phase, I communicated with and updated the team 
regularly. If funding was available, it would have been ideal to have hired a research 
nurse to assist in the identification of eligible participants. Furthermore, I had hoped 
that posters created to drive recruitment would be more effective. It is not known 
exactly how many people came across the empirical study via the posters.  
In my original plan, I had hoped that staff would be able to facilitate 
recruitment in my absence; however, it became clear that my presence was required to 
drive recruitment. This was not always feasible due to placement commitments, and 
ultimately meant I was not able to attend most of the clinics in one recruitment site. 
As the diabetes team were not familiar with the research, they would often defer to me 
to introduce the project. I alleviated these issues by creating a video and PowerPoint 
slide that they could show to potential participants. On reflection, it would have been 
helpful to have collaborated with the diabetes team more to expand the sense of 
ownership over the project. Embedding the research into the service would increase 
its feasibility and help address recruitment issues, but it would also be important to 
consider organisational readiness and capacity for implementing research initiatives. I 
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hope to learn from this by involving more service users and clinicians in the 
development of future recruitment strategies. 
My recruitment target was based on a power calculation and I found this to be 
feasible based on a previous study which recruited in the same diabetes clinics 
(Taylor, 2012). I chose to recruit people with insulin-treated diabetes as they are more 
commonly seen in these clinics. However, this is a small population with significant 
disease burden. I found that they were more likely to miss their appointments or be 
less open to discussions around diabetes. Due to the stringent HbA1c criteria, there 
were potential participants who were excluded despite showing an interest. In future 
studies, it would be beneficial to broaden inclusion criteria as feedback from 
participants suggested that high HbA1c is not necessarily representative of how an 
individual is coping psychologically with their diabetes.  
I was aware of the need to over-recruit participants to meet the target sample 
size. However, delays in receiving NHS ethics approval and the reduction in clinics 
over the winter holidays slowed recruitment. To increase my recruitment rate, I 
expanded the target sample to include individuals from diabetes charity organisations. 
Expanding recruitment to other NHS trusts was considered but was not feasible given 
time restraints. Despite my best efforts, I did not achieve my target sample size. This 
issue is not uncommon as the target sample size for recruitment is met in 56% of 
RCTs (Walters et al., 2017). Through the project, I have gained a better understanding 
of realistic recruitment figures and gained an insight into some of the research barriers 
faced by people with diabetes. 
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Reflections on study methodology 
Due to the small sample size, I was not able to statistically compare the two 
interventions. Furthermore, as the study was underpowered, the conclusions were 
based on theoretical inferences. This limits the extent to which the study findings can 
be interpreted. Furthermore, whilst I planned to carry out an RCT, the final design is 
more akin to a quasi-experimental design. To achieve the target sample size, I took a 
more flexible approach to the controls than planned, such as the intervention 
completion time, but this introduced confounding factors. Additionally, it was not 
easy to obtain HbA1c values at follow-up as I had to rely on routine blood tests which 
occur every three to 12 months. In the future I hope to learn from this by altering my 
study design rather than reducing control, such as using pragmatic trials as an 
alternative to RCTs to identify implementation challenges (MacPherson, 2004).   
Upon discussing my exclusion criteria with the diabetes team, it became clear 
that through excluding non-English speaking individuals and those without Internet 
access, I was losing a large proportion of the diabetes population. However, this felt 
necessary due to the pilot stage of research and a lack of funding to produce multi-
language versions. I felt that these reasons justified the exclusion criteria, but in future 
research it is important to consider how to make the interventions accessible to a 
broader population.  
To ensure that the intervention was adapted appropriately for the population, I 
attempted to target my intervention design to create a user-friendly experience. I 
ensured that participants could engage with mindfulness practice by easing them into 
practices that built in complexity. Nevertheless, I could have made some 
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improvements, such as incorporating a motivational amplifier into the VGI as it can 
be beneficial for individuals to imagine achieving a goal (Renner et al., 2019).  
As eluded to in the prior sections, this study had a high attrition rate of 48.2% 
with an acceptable attrition rate in RCTs being considered <20% (Amico, 2009). This 
can be explained by potential barriers such as navigating the online format of the 
study. Participants were occasionally met with technical issues which may have 
increased dropout rates. In hindsight, it would have been valuable to track this data to 
better understand the feasibility of online ACT-based interventions. Furthermore, 
feedback from participants who withdrew from the study made me aware of some 
issues with the intervention. People saw the intervention as too much of a 
commitment and therefore it required additional input to keep them engaged. 
Interestingly, some participants appeared demotivated during the study following the 
introduction to mindfulness as they had preconceived notions on its effectiveness for 
supporting their diabetes, which could have impacted outcomes (Harvey & Lawson, 
2009). 
Reflections on service user involvement 
The ladder of participation framework was used to evaluate the level of 
service user involvement (Arnstein, 1969). Due to time and resource constraints, 
service users were not involved in the development and completion of the systematic 
review; they were informed of the review when consulted about the empirical project. 
Whilst informing service users is considered the first step of participation, it falls 
within the “tokenism” category of the ladder as service users are not given the 
opportunity to share their views. Rutter and colleagues (2011) emphasised the need 
for active service user involvement in conducting systematic reviews, not only to 
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inform the selection of a review topic that is meaningful and relevant but also to 
ensure service user knowledge is considered in interpreting the findings.  
The level of service user involvement in the empirical study would fall under 
the “consultation” category of the ladder. Attempts were made to identify service 
users to consult within the services where recruitment took place; however, a 
dedicated diabetes service user group was not available. Consequently, facilitators and 
members of local Diabetes UK groups were consulted regarding the relevance and 
acceptability of the study. As most members were older adults, I sought feedback 
from two young adults with T1D to ensure that the views obtained represented the age 
diversity of the population. Feedback was sought on draft versions of study 
documents, interventions and outcome measures. This resulted in improvements to the 
recruitment poster, adaptations to one of the interventions, and refinement of the 
research design. 
Overall, due to course timetabling, service users had limited influence on the 
overall direction that the project took as this had been approved in advance. In 
hindsight, approaching service users prior to the development of the project proposal 
would have enabled more participatory involvement as captured by the “partnership” 
section of the ladder and encouraged co-production of the project. Further, access to 
funding and training would have enabled service user involvement in all stages of the 
research cycle as advised by the NIHR (2018). With regards to dissemination, it is 
planned to invite a service user involved from the earlier consultations to co-present 
the study findings to the diabetes team in ASPH NHS Foundation Trust at one of their 
internal seminars. 
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Impact 
Clinical impact 
There is a clear need for psychological interventions to support people with 
diabetes (Askew & Solomons, 2019). Whilst we discovered some interesting findings, 
the results were mostly inconclusive. However, a key area where we can comment is 
in the area of diabetes self-management. This aspect showed an improvement, 
potentially supporting future implementation of an ACT component-based 
intervention for diabetes self-management. As this would be a cost-effective and easy 
to administer intervention, this could potentially help people with diabetes to reduce 
their disease burden as demonstrated by a clinically significant reduction in HbA1c in 
a small number of patients. The key focus of the diabetes clinic was on individuals’ 
physical health. The intervention may have improved individuals’ awareness of their 
well-being as this was an area of focus for my research. Furthermore, engaging with 
this population helped to increase awareness of various concepts such as mindfulness 
and value-based living.  
Improving diabetes self-management would have broader benefits for the 
NHS and clinicians working with this population. Self-management can ultimately 
reduce the economic burden of diabetes, which would mean more available resources 
for the NHS (Diabetes UK, 2019). Furthermore, there is a high turnover and patient 
load in diabetes clinics, which could be eased with the use of online interventions. 
Diabetes organisations may also benefit from using online interventions. As these are 
easier to disseminate, individuals could be directed to online interventions for their 
specific needs which could help to improve their outcomes. Furthermore, these 
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organisations run groups where individuals could come together to discuss and share 
any online interventions they use.  
As this was a pilot study, it is unlikely that the results will influence policy 
makers or development of guidelines at this stage. However, it is possible that 
services at a local level may begin to address local needs and to consider carrying out 
further research into this area due to the potential cost-saving benefits (Diabetes UK, 
2010). This may eventually translate into larger policy driving work. Furthermore, a 
simple local implementation may be to introduce a screening questionnaire to identify 
individuals in need of psychological support regarding their diabetes. A key barrier to 
acting on the burden of psychological need is funding, which may be easier to address 
once further research is carried out.   
Academic impact 
The systematic review brought together the ACT for diabetes literature. As no 
previous review had done this, it provides future researchers with a good foundation 
to build on and recommendations for future research. Additionally, it will provide a 
reference for future work and help guide researchers when conducting studies in the 
T1D population.  
The empirical study may draw the attention of researchers interested in 
diabetes as well as ACT. This is due to the relatively novel ACT component-based 
approach that the interventions used. Individuals interested in ACT may find valuable 
information on adapting ACT components for their own area of research, such as in 
chronic pain management where ACT is already established (Hughes et al., 2017). 
Furthermore, the use of online ACT-based interventions contributes to the growing 
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literature on technology-based interventions. By carrying out a pilot study that aimed 
to be robust and transparent, I have highlighted many implementation challenges and 
given a clear attrition rate to inform future study designs. Further robust RCTs are 
required to establish the effectiveness of these interventions.  
Dissemination 
Effective dissemination to a variety of audiences is an important pathway to 
maximise impact (National Institute for Health Research, 2019). Firstly, all 
participants will be provided with a plain English summary of the findings if they 
opted to receive this, as it is best practice to feedback the research outcomes towards 
which participants have contributed (HRA, 2018). This summary will also be 
provided to the local Diabetes UK groups that were consulted, through their 
newsletters to members. I will consult group facilitators for any suggestions about 
how and with whom the findings should be disseminated. The same summary will be 
shared with Diabetes UK, JDRF and IDDT, encouraging them to share the findings 
via their website and/or social media pages, such as Facebook, Twitter and LinkedIn. 
This is an important step as they are reputable organisations that connect with many 
people with diabetes, which increases the reach and potential impact of the study 
findings. A formal summary of the findings will be provided to the diabetes team at 
ASPH NHS Foundation Trust and presented at one of their internal seminars with a 
service user. To maximise the impact of disseminating the study findings to the 
diabetes team, I will ensure that I put the findings into context and highlight the 
recommendations that are most pertinent to their clinical practice. 
The empirical study findings were disseminated via a recorded presentation to 
trainee clinical psychologists and staff members in the Department of Clinical 
136 
 
Psychology at Royal Holloway, University of London. To maximise the reach of the 
systematic review and the empirical study, they will be submitted to a high-quality 
peer-reviewed diabetes journal such as Diabetes Care or Diabetes Research and 
Clinical Practice for publication. Both are leading high impact journals in the diabetes 
field and encourage dissemination of psychosocial research. Peer-reviewed health 
psychology journals such as the British Journal of Health Psychology could also be 
considered. Alongside this, I have planned to present my empirical study as part of a 
symposium submission on ACT components at the UK & Ireland Association for 
Contextual Behavioural Science 2020 conference as this would be a good opportunity 
to target researchers and clinicians with an interest in ACT. A submission had been 
made to present the empirical study at the British Association for Behavioural and 
Cognitive Psychotherapies annual conference in July 2020. As the conference has 
been cancelled, I plan to re-submit the project once the conference is rescheduled. 
Through making the research widely available, it is hoped that clinicians and 
researchers will be encouraged to expand the ACT for diabetes literature and to 
consider investigating modular and online ACT-based interventions. 
To evidence that effective dissemination had taken place, it would be useful to 
seek feedback from participants, Diabetes UK local groups, diabetes organisations 
and the diabetes team about the study findings’ clarity, usefulness, applicability to 
clinical practice and/or to real-life, through a brief, open-ended questionnaire. 
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Appendix A: Eligibility Criteria 
 Inclusion criteria Exclusion criteria 
Design Quantitative experimental 
and quasi-experimental 
designs 
Quantitative description and 
correlational designs, 
qualitative designs, study 
protocols, systematic 
reviews, meta-analyses 
Participant 
Characteristics 
T1D or T2D, any age group, 
any ethnicity 
Gestational diabetes, 
diabetes insipidus, steroid-
induced diabetes, type 3 
diabetes 
Setting Any N/A 
Dates All N/A 
Language English Non-English 
Methodology   
- Intervention 
Type 
Any form of ACT-based 
intervention (individual, 
group, online) including 
both acceptance and 
commitment components 
Non-ACT-based 
interventions, or ACT-based 
interventions that only 
include one component 
- Measure Diabetes-related outcomes 
obtained using standardised 
measures 
Outcomes unrelated to 
diabetes or use of 
unstandardised measures  
 
 
  
162 
 
Appendix B: London – Surrey Research Ethics Committee Letter of Ethical 
Approval (08/08/19) 
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Appendix C: Health Research Authority Letter of Ethical Approval (03/10/19) 
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Appendix D: Ethical Approval from Research Ethics Committee at Royal 
Holloway, University of London (23/10/19) 
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Appendix E: Letter of Access from the Research and Development Department 
at Ashford and St Peter’s Hospitals (ASPH) NHS Foundation Trust (10/10/19) 
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Appendix F: Participants’ Sociodemographic Characteristics and Pre-
Intervention Scores by Group Condition 
Table F1 
Participants’ Sociodemographic Characteristics by Group Condition 
Sociodemographic 
Characteristics –  M (SD) 
MBI 
(n = 12) 
VGI 
(n = 17) 
Total 
(n = 29) 
Test 
Statistic 
Age 51.3 (12.5) 45.7 (18.1) 48.0 (16.0) t(24.9) = .99,  
p = .35b 
Gender – n 
(%) 
– Female 5 (41.7%) 8 (52.9%) 13 (44.8%) 
χ2(1) = .083,  
p = .77 – Male 7 (58.3%) 9 (47.1%) 16 (55.2%) 
Ethnicity – n 
(%) 
– White 12 (100%) 16 (94.1%) 28 (96.6%) 
χ2(2) = 1.52,  
p = .47 
– Asian 0 (0%) 1 (5.88%) 1 (3.45%) 
– Black 0 (0%) 0 (0%) 0 (0%) 
– Mixed 0 (0%) 0 (0%) 0 (0%) 
– Other 0 (0%) 0 (0%) 0 (0%) 
Marital status 
– n (%) 
– Single 0 (0%) 6 (35.3%) 6 (20.7%) 
χ2(3) = 6.56,  
p = .08 
– Married/ 
   Living with 
   partner 
 
10 (83.3%) 8 (47.1%) 18 (62.1%) 
– Divorced/ 
   Separated 
2 (16.7%) 2 (11.8%) 4 (13.8%) 
– Widowed 0 (0%) 1 (5.90%) 1 (3.40%) 
Employment 
status – n (%) 
– Working  
   full-time 
6 (50.0%) 9 (52.9%) 15 (51.7%) 
χ2(3) = 2.62,  
p = .46 
– Working  
   part-time 
4 (33.3%) 2 (11.8%) 6 (20.7%) 
– Not  
   working 
1 (8.30%) 2 (11.8%) 3 (10.3%) 
– Retired 1 (8.30%) 4 (23.5%) 5 (17.2%) 
Age leaving education (years) 19.9 (5.30) 18.5 (3.08)a 19.1 (4.15) t(26) = .89,  
p = .38 
Body mass index (kg/m2)  27.1 (4.03) 29.5 (6.38)a 28.5 (5.54) t(26) = -1.14, 
p = .27 
Diabetes type  
– n (%) 
– Type 1 9 (75.0%) 13 (76.5%) 22 (75.9%) 
χ2(1) = .008,  
p = 1.00 – Type 2 3 (25.0%) 4 (23.5%) 7 (24.1%) 
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Note. a Based on n = 16 due to missing data; b  Based on n = 11 due to missing data; c 
t-statistic calculated without assumption of equal variances as Levene’s test was 
significant (p = .012) 
 
Table F2 
Participants’ Pre-Intervention Scores on Outcome Measures and Process Measures 
Note. a n = 11 due to removal of outlier; DSMQ = Diabetes Self-Management 
Questionnaire; W-BQ28 = Well-being Questionnaire; HbA1c = glycated haemoglobin; 
DAS = Diabetes Acceptance Scale; VLQ = Valued Living Questionnaire 
 
 
Diabetes duration (years) 22.3 (13.1) 21.6 (16.5) 21.9 (15.0) t(27) = .11,  
p = .92 
Insulin treatment duration 
(years) 
18.1 (15.5) 18.9 (17.5) 18.6 (16.4) t(27) = -.132, 
p = .90 
Insulin 
treatment 
regime – n (%) 
– Pen 8 (66.7%) 16 (94.1%) 24 (82.8%) 
χ2(2) = 3.92,  
p = .14 
– Pump 3 (25.0%) 1 (5.9%) 4 (13.8%) 
– Syringe 1 (8.30%) 0 (0%) 1 (3.40%) 
No of insulin injections per day 4.00 (1.73)b 3.88 (0.62)a 3.93 (1.17) t(27) = .27,  
p = .79 
No of hypoglycaemic episodes 
in last 2 months 
6.08 (1.73) 6.76 (0.90) 6.48 (1.33) 
t(15.3) = -
1.25, p = 
.23c 
Diabetes complications – n (%) 5 (41.7%) 7 (41.2%) 12 (41.4%) χ
2
(1) = .001,  
p = .98 
Other health conditions – n (%) 6 (50.0%) 9 (52.9%) 15 (51.7%) χ
2
(1) = .024,  
p = .88 
Pre-Intervention Scores – M 
(SD) 
MBI 
(n = 12) 
VGI 
(n = 17) 
Total 
(n = 29) 
Test 
Statistic 
DSMQ 6.79 (1.46) 6.40 (1.46) 6.56 (1.45) 
t(27) = .71,  
p = .49 
W-BQ28 – Diabetes-Specific 22.8 (9.94) 19.2 (10.4) 20.7 (10.2) 
t(27) = .93,  
p = .36 
HbA1c 75.6 
(7.62)a 
77.9 (10.5) 77 (9.39) 
t(26) = -.61,  
p = .55 
VLQ 51.1 (20.8) 43.3 (22.4) 46.5 (21.7) 
t(27) = .95,  
p = .35 
DAS 46.1 (10.2) 40.4 (13.9) 42.8 (12.6) 
t(27) = 1.20,  
p = .24 
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Appendix G: Recruitment Poster and Leaflet 
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Appendix H: Participant Information Sheet 
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Appendix I: Consent Form 
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Appendix J: Sociodemographic Questionnaire 
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Appendix K: Well-Being Questionnaire (W-BQ28) 
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Appendix L: Diabetes Self-Management Questionnaire (DSMQ) 
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Appendix M: Diabetes Acceptance Scale (DAS) 
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Appendix N: Valued Living Questionnaire (VLQ) 
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Appendix O: Programme Feedback Questionnaire 
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Appendix P: Values-plus-Goals Intervention Protocol 
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Weekly Progress Check Example in the Values-plus-Goals Intervention 
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Appendix Q: Mindfulness-based Intervention Protocol 
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Ten-minute Health-focused Guided Mindfulness Meditation Exercise – Script 
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Weekly Progress Check Example in the Mindfulness-based Intervention 
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Appendix R: Reliable Change Indices for Well-Being and Diabetes Self-
Management, and Raw Differences in HbA1c Values 
 
Table R1 
Reliable Change Indices for Well-Being and Diabetes Self-Management in the 
Mindfulness-Based Intervention 
 
 Reliable Change Indices across Time Points 
 Well-being  Diabetes self-management 
Participant T1 - T2 T2 - T3 T1 - T3  T1 - T2 T2 - T3 T1 - T3 
P1 -0.190 0.190 0.000  -1.009 -0.252 -1.261 
P2 0.000 -0.190 -0.190  -0.757 1.009 0.252 
P3 0.000 0.380 0.380  0.000 1.513 1.513 
P4 -0.380 N/A N/A  0.000 N/A N/A 
P5 2.092* N/A N/A  -0.252 N/A N/A 
P6 2.472* -1.331 1.141  2.270* -0.757 1.513 
P7 0.380 -0.761 -0.380  0.504 -0.504 0.000 
P8 -0.571 0.761 0.190  -1.261 0.000 -1.261 
P9 0.761 -0.380 0.380  0.504 0.757 1.261 
P10 -0.571 1.331 0.761  2.270* -0.252 2.018* 
P11 -0.571 N/A N/A  1.009 N/A N/A 
P12 0.000 N/A N/A  1.009 N/A N/A 
Note. * p < .05 
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Table R2 
Reliable Change Indices for Well-Being and Diabetes Self-Management in the 
Values-plus-Goals Intervention 
 
 Reliable Change Indices across Time Points 
 Well-being  Diabetes self-management 
Participant T1 – T2 T2 – T3 T1 – T3  T1 – T2 T2 – T3 T1 – T3 
P13 -0.182 N/A N/A  -1.261 N/A N/A 
P14 1.635 N/A N/A  1.766 N/A N/A 
P15 -0.182 0.182 0.000  0.757 -0.252 0.504 
P16 0.182 0.182 0.363  -0.252 0.000 -0.252 
P17 -0.909 -0.363 -1.272  -1.261 -0.252 -1.513 
P18 0.363 N/A N/A  2.018* N/A N/A 
P19 -0.727 0.363 -0.363  0.504 -0.252 0.252 
P20 2.726* N/A N/A  1.009 N/A N/A 
P21 0.000 -0.909 -0.909  0.757 0.252 1.009 
P22 0.545 1.272 1.817  3.027* -0.757 2.270* 
P23 -0.182 1.454 1.272  2.018* -0.504 1.513 
P24 -0.182 0.182 0.000  0.757 0.252 1.009 
P25 0.363 0.000 0.363  1.766 1.513 3.279* 
P26 -1.090 0.545 -0.545  -0.252 -0.252 -0.504 
P27 1.635 N/A N/A  2.018* N/A N/A 
P28 0.363 0.363 0.727  0.504 0.500 1.005 
P29 0.909 N/A N/A  0.504 N/A N/A 
Note. * p < .05 
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Table R3 
Raw Difference in HbA1c Values across Both Conditions 
a 
Condition – Participant Pre-Post Change in HbA1c (mmol/mol) 
VGI – P1 –9* 
VGI – P2 –28* 
VGI – P3 +1 
VGI – P4 –14* 
VGI – P5 –8* 
MBI – P3 +5 
MBI – P5 -15* 
Note. a Data is only reported for participants whose follow-up HbA1c was obtained; + 
and – symbols indicate an increase and decrease in HbA1c value respectively; * 
Clinically significant change (>5.5 mmol/mol)  
 
 
 
 
